10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 29, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number 0-13200

AstroNova, Inc.

(Exact name of registrant as specified in its charter)

Rhode Island	05-0318215
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
600 East Greenwich Avenue, West Warwick, Rhode Island	02893
(Address of principal executive offices)	(Zip Code)

(401) 828-4000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $.05 Par Value	ALOT	NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ☐    No  ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of December 5, 2022 was 7,349,507.

ASTRONOVA, INC.

INDEX

		Page No.
Part I.	Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets – October 29, 2022 and January 31, 2022		1
	Unaudited Condensed Consolidated Statements of Income — Three and Nine Months Ended October 29, 2022 and October 30, 2021		2
	Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) — Three and Nine Months Ended October 29, 2022 and October 30, 2021		3
	Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity — Three and Nine Months Ended October 29, 2022 and October 30, 2021		4
	Unaudited Condensed Consolidated Statements of Cash Flows — Nine Months Ended October 29, 2022 and October 30, 2021		5
	Notes to the Condensed Consolidated Financial Statements (unaudited)		6-22
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		23-33
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		34
Item 4.	Controls and Procedures		34
Part II.	Other Information
Item 1.	Legal Proceedings		34
Item 1A.	Risk Factors		34-35
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		35
Item 6.	Exhibits		36
Signatures			37

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share Data)

	October 29, 2022			January 31, 2022
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	$	4,496		$	5,276
Accounts Receivable, net		21,919			17,124
Inventories, net		49,992			34,609
Employee Retention Credit Receivable		—			3,135
Prepaid Expenses and Other Current Assets		4,682			3,634
Total Current Assets		81,089			63,778
Property, Plant and Equipment, net		14,041			11,441
Intangible Assets, net		18,866			19,200
Goodwill		17,885			12,156
Deferred Tax Assets		5,567			5,591
Right of Use Assets		800			1,094
Other Assets		1,581			1,695
TOTAL ASSETS	$	139,829		$	114,955
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable	$	9,644		$	8,590
Accrued Compensation		2,814			3,512
Other Liabilities and Accrued Expenses		4,006			4,113
Revolving Line of Credit		19,900			—
Current Liability – Royalty Obligation		1,750			2,000
Current Portion of Long-Term Debt		1,800			1,000
Current Liability – Excess Royalty Payment Due		255			235
Income Taxes Payable		912			323
Deferred Revenue		362			262
Total Current Liabilities		41,443			20,035
Long-Term Debt, net of current portion		12,732			8,154
Royalty Obligation, net of current portion		3,298			4,361
Lease Liabilities, net of current portion		550			808
Income Taxes Payable		399			399
Deferred Tax Liabilities		79			186
TOTAL LIABILITIES		58,501			33,943
SHAREHOLDERS’ EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,669,689 shares and 10,566,404 shares at October 29, 2022 and January 31, 2022, respectively		534			528
Additional Paid-in Capital		60,774			59,692
Retained Earnings		57,812			56,514
Treasury Stock, at Cost, 3,341,354 and 3,324,280 shares at October 29, 2022 and January 31, 2022, respectively		(34,227	)		(33,974	)
Accumulated Other Comprehensive Loss, net of tax		(3,565	)		(1,748	)
TOTAL SHAREHOLDERS’ EQUITY		81,328			81,012
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	139,829		$	114,955

See Notes to condensed consolidated financial statements (unaudited).

1

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(In Thousands, Except Per Share Data)

(Unaudited)

	Three Months Ended						Nine Months Ended
	October 29, 2022			October 30, 2021			October 29, 2022			October 30, 2021
Revenue	$	39,405		$	28,857		$	102,674		$	87,780
Cost of Revenue		26,923			18,472			68,080			53,792
Gross Profit		12,482			10,385			34,594			33,988
Operating Expenses:
Selling and Marketing		5,908			5,777			17,771			16,931
Research and Development		1,903			1,948			5,021			5,203
General and Administrative		3,325			2,364			8,456			7,372
Operating Expenses		11,136			10,089			31,248			29,506
Operating Income		1,346			296			3,346			4,482
Other Income (Expense), net:
Extinguishment of Debt – PPP Loan		—			—			—			4,466
Loss on Disposal of Assets		—			(696	)		—			(696	)
Interest Expense		(701	)		(135	)		(1,086	)		(526	)
Loss on Foreign Currency Transactions		(237	)		(117	)		(614	)		(231	)
Other, net		(17	)		53			35			(11	)
		(955	)		(895	)		(1,665	)		3,002
Income (Loss) Before Income Taxes		391			(599	)		1,681			7,484
Income Tax Provision (Benefit)		102			(174	)		383			297
Net Income (Loss)	$	289		$	(425	)	$	1,298		$	7,187
Net Income (Loss) per Common Share—Basic:	$	0.04		$	(0.06	)	$	0.18		$	1.00
Net Income (Loss) per Common Share—Diluted:	$	0.04		$	(0.06	)	$	0.18		$	0.98
Weighted Average Number of Common Shares Outstanding:
Basic		7,324			7,234			7,299			7,196
Diluted		7,379			7,234			7,363			7,325

See Notes to condensed consolidated financial statements (unaudited).

2

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In Thousands)

(Unaudited)

	Three Months Ended						Nine Months Ended
	October 29, 2022			October 30, 2021			October 29, 2022			October 30, 2021
Net Income (Loss)	$	289		$	(425	)	$	1,298		$	7,187
Other Comprehensive Loss, Net of Taxes:
Foreign Currency Translation Adjustments		(497	)		(410	)		(1,864	)		(839	)
Loss from Cash Flow Hedges Reclassified to Income Statement		16			16			47			47
Other Comprehensive Loss		(481	)		(394	)		(1,817	)		(792	)
Comprehensive Income (Loss)	$	(192	)	$	(819	)	$	(519	)	$	6,395

See Notes to condensed consolidated financial statements (unaudited).

3

ASTRONOVA, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

($ In Thousands, Except per Share Data)

(Unaudited)

	Common Stock				Additional Paid-in Capital			Retained Earnings		Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
	Shares		Amount
Balance January 31, 2022		10,566,404	$	528	$	59,692		$	56,514	$	(33,974	)	$	(1,748	)	$	81,012
Share-Based Compensation		—		—		337			—		—			—			337
Employee Option Exercises		11,164		1		87			—		—			—			88
Restricted Stock Awards Vested, net		61,513		3		(3	)		—		(249	)		—			(249	)
Net Income		—		—		—			425		—			—			425
Other Comprehensive Loss		—		—		—			—		—			(917	)		(917	)
Balance April 30, 2022		10,639,081	$	532	$	60,113		$	56,939	$	(34,223	)	$	(2,665	)	$	80,696
Share-Based Compensation		—		—		235			—		—			—			235
Restricted Stock Awards Vested, net		20,410		1		(1	)		—		—			—			—
Net Income		—		—		—			584		—			—			584
Other Comprehensive Loss		—		—		—			—		—			(419	)		(419	)
Balance July 30, 2022		10,659,491	$	533	$	60,347		$	57,523	$	(34,223	)	$	(3,084	)	$	81,096
Share-Based Compensation		—		—		405			—		—			—			405
Employee Option Exercises		9,097		1		22			—		—			—			23
Restricted Stock Awards Vested, net		1,101		—		—			—		(4	)		—			(4	)
Net Income		—		—		—			289		—			—			289
Other Comprehensive Loss		—		—		—			—		—			(481	)		(481	)
Balance October 29, 2022		10,669,689	$	534	$	60,774		$	57,812	$	(34,227	)	$	(3,565	)	$	81,328

	Common Stock				Additional Paid-in Capital			Retained Earnings			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total Shareholders’ Equity
	Shares		Amount
Balance January 31, 2021		10,425,094	$	521	$	58,049		$	50,085		$	(33,588	)	$	(384	)	$	74,683
Share-Based Compensation		—		—		478			—			—			—			478
Employee Option Exercises		5,746		—		52			—			—			—			52
Restricted Stock Awards Vested, net		48,299		3		(3	)		—			(208	)		—			(208	)
Net Income		—		—		—			593			—			—			593
Other Comprehensive Loss		—		—		—			—			—			(65	)		(65	)
Balance May 1, 2021		10,479,139	$	524	$	58,576		$	50,678		$	(33,796	)	$	(449	)	$	75,533
Share-Based Compensation		—		—		469			—			—			—			469
Employee Option Exercises		3,211		—		35			—			—			—			35
Restricted Stock Awards Vested, net		72,125		4		(4	)		—			(146	)		—			(146	)
Net Income		—		—		—			7,019			—			—			7,019
Other Comprehensive Loss		—		—		—			—			—			(333	)		(333	)
Balance July 31, 2021		10,554,475	$	528	$	59,076		$	57,697		$	(33,942	)	$	(782	)	$	82,577
Share-Based Compensation		—		—		399			—			—			—			399
Employee Option Exercises		1,983		—		27			—			—			—			27
Restricted Stock Awards Vested, net		433		—		—			—			(2	)		—			(2	)
Net Loss		—		—		—			(425	)		—			—			(425	)
Other Comprehensive Loss		—		—		—			—			—			(394	)		(394	)
Balance October 30, 2021		10,556,891	$	528	$	59,502		$	57,272		$	(33,944	)	$	(1,176	)	$	82,182

4

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

	Nine Months Ended
	October 29, 2022			October 30, 2021
Cash Flows from Operating Activities:
Net Income	$	1,298		$	7,187
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:
Depreciation and Amortization		2,621			3,070
Amortization of Debt Issuance Costs		18			38
Share-Based Compensation		977			1,345
Loss on Disposal of Assets		—			696
Gain on Extinguishment of Debt		—			(4,466	)
Changes in Assets and Liabilities, net of impact of acquisition:
Accounts Receivable		(1,874	)		969
Other Receivable – Employee Retention Credit Receivable		3,135			(3,135	)
Inventories		(11,695	)		(1,804	)
Income Taxes		142			(1,965	)
Accounts Payable and Accrued Expenses		(1,207	)		2,914
Other		(870	)		(1,001	)
Net Cash Used Provided (Used) by Operating Activities		(7,455	)		3,848
Cash Flows from Investing Activities:
Cash Paid for Astro Machine Acquisition, net of acquired cash		(17,034	)		—
Additions to Property, Plant and Equipment		(222	)		(1,507	)
Net Cash Used for Investing Activities		(17,256	)		(1,507	)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans		69			47
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan		42			67
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock		(253	)		(356	)
Net Borrowings under Revolving Credit Facility		19,900			—
Payment of Minimum Guarantee Royalty Obligation		(1,500	)		(1,500	)
Proceeds from Long-Term Debt Borrowings		6,000			10,000
Payoff of Long-Term Debt		—			(12,576	)
Principal Payments of Long-Term Debt		(625	)		(563	)
Payment of Debt Issuance Costs		(15	)		—
Net Cash Provided (Used) by for Financing Activities		23,618			(4,881	)
Effect of Exchange Rate Changes on Cash and Cash Equivalents		313			(172	)
Net Decrease in Cash and Cash Equivalents		(780	)		(2,712	)
Cash and Cash Equivalents, Beginning of Period		5,276			11,439
Cash and Cash Equivalents, End of Period	$	4,496		$	8,727
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	$	440		$	268
Cash Paid During the Period for Income Taxes, Net of Refunds	$	265		$	2,243

 See Notes to condensed consolidated financial statements (unaudited).

5

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation industries.

Our business consists of two segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel®, TrojanLabel®, and GetLabels™ brand names. The T&M segment consists of our line of aerospace products, including flight deck printers, networking hardware, and related accessories as well as test and measurement data acquisition systems sold under the AstroNova® brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding, and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers, direct-to-package printers, high-volume presses, and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, allowing customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers, as well as airborne networking hardware for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. On August 4, 2022, we completed the acquisition of Astro Machine, an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $17.1 million. Astro Machine is reported as part of our Product Identification segment beginning with the third quarter of fiscal 2023. Refer to Note 3, “Acquisition,” in our condensed consolidated financial statements included elsewhere in this report for further details.

Our PI products are sold by direct field salespersons as well as independent dealers and representatives, while our T&M products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in PI products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.

Unless otherwise indicated, references to “AstroNova”, “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information, in the context of the unknown future impacts of the continuing COVID-19 pandemic, using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, warranty reserves reserves and the purchase price accounting associated with the acquisition of Astro Machine as further discussed in Note 3 “Acquisition”. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope, and severity of the COVID-19 pandemic. Although conditions have improved in the U.S. in recent months, on October 13, 2022, the US Secretary of Health and Human Services extended the COVID-19 public health emergency declaration through at least January 11, 2023. Consequently, actual results could differ from those estimates.

6

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year’s financial statements have been reclassified to conform to the current year’s presentation.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Note 2 – Summary of Significant Accounting Policies Update

The accounting policies used in preparing the condensed consolidated financial statements in this Form 10-Q are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

Recently Adopted Accounting Pronouncements

No new accounting pronouncements, issued or effective during the first nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Note 3 - Acquisition

On August 4, 2022, we acquired Astro Machine LLC (“Astro Machine”), an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $17.1 million.

The acquisition was accomplished pursuant to an Equity Interest Purchase Agreement dated as of August 4, 2022 (the “Purchase Agreement”) by and among us, GSND Holding Corporation (“GSND”), the parent company of Astro Machine, and Astro Machine. Pursuant to the Purchase Agreement, we purchased 100% of the issued and outstanding equity interests of Astro Machine from GSND for a purchase price of $15.6 million. The acquisition was funded using borrowings under our credit facility. We obtained a representation and warranty insurance policy and placed $300,000 of the purchase price into an escrow account, which pursuant to the terms and conditions of the Purchase Agreement, are our sole recourse for breaches of representations and warranties by GSND. Upon the closing of the transaction, Astro Machine became a wholly owned subsidiary of AstroNova, Inc.

Concurrently with the signing of the Purchase Agreement, our newly acquired subsidiary, Astro Machine, entered into a Purchase and Sale Agreement with Selak Real Estate Limited Partnership (“SRE”), pursuant to which Astro Machine purchased certain real property assets of SRE for a purchase price, paid in cash, of $1.5 million. These real estate assets are comprised of a 34,460 square foot industrial manufacturing building (including offices) on 1.26 acres of land which is Astro Machine’s principal place of business.

This transaction is a business combination and will be accounted for using the acquisition method of accounting prescribed by ASC Topic 805, Business Combinations (“ASC 805”), whereby the results of operations, including the revenues and earnings of Astro Machine, are included in our financial statements from the date of acquisition. The purchase price of Astro Machine will be allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair value based on widely accepted valuation techniques in accordance with ASC Topic 820, Fair Value Measurements, at the acquisition date. Any excess of the purchase price over the fair value of the net identified assets acquired and liabilities assumed will be recorded as goodwill. The process for estimating fair values requires the use of significant estimates, assumptions and judgments, including determining the timing and estimates of future cash flows and developing appropriate discount rates. ASC 805 establishes a measurement period to provide companies with a reasonable amount of time to obtain the information necessary to identify and measure various items in a business combination and cannot extend beyond one year from the acquisition date. We expect to complete the final fair value determination of the assets acquired and liabilities assumed as soon as practicable within the measurement period and in any event not later than one year from the acquisition date.

Total acquisition-related costs to date of $0.7 million are included in the general and administrative expenses in our consolidated statement of income for the nine months ended October 29, 2022.

7

The preliminary allocation of the purchase price as of October 29, 2022, is as follows:

(In thousands)
Cash	$	91
Accounts Receivable		3,393
Inventory		4,557
Property, Plant and Equipment		3,867
Identifiable Intangible Assets		1,000
Goodwill		6,567
Accounts Payable and Other Current Liabilities		(2,350	)
Total Purchase Price	$	17,125

The amounts above are provisional and are based on information that is currently available. Management believes the information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significanct. Management anticipates changes to the value of inventory, property, plant and equipment, deferred taxes and identifiable intangible assets as additional information is collected and analyzed and pending the completion of certain appraisals and a valuation report and expects to finalize the valuation and complete the purchase price allocation as soon as practicable but no later than one year from the acquisition.

The following table reflects the preliminary fair value of the acquired identifiable intangible asset and related estimated useful lives:

(In thousands)	Fair Value		Useful Life (Years)
Customer Relations	$	1,000		7

The Customer Relations intangible asset represents the relationships that will be maintained with certain historical customers of Astro Machine. This amount was estimated by our management based upon information known as of the date of filing and is subject to change pending completion of the formal valuation report.

Beginning August 4, 2022, the results of operations for Astro Machine have been included in our statement of income for the three and nine months ended October 29, 2022, and are reported as part of the Product Identification segment.

8

Note 4 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems, and airborne printers and networking hardware used in the flight deck and cabin of military, commercial, and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
United States	$	26,806	$	17,280	$	65,501	$	51,154
Europe		7,341		7,163		22,642		23,588
Canada		2,253		1,724		6,333		4,761
Asia		1,392		1,473		4,118		4,523
Central and South America		1,311		814		3,222		2,569
Other		302		403		858		1,185
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

Major product types:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Hardware	$	11,947	$	7,622	$	29,885	$	23,147
Supplies		22,945		18,055		60,055		54,944
Service and Other		4,513		3,180		12,734		9,689
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

9

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.

Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $362,000 and $262,000 at October 29, 2022, and January 31, 2022, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The increase in the deferred revenue balance during the nine months ended October 29, 2022, is due to cash payments received in advance of satisfying performance obligations in the current period, offset by $226,000 of revenue recognized during the period that was included in the deferred revenue balance at January 31, 2022.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized over the remaining useful life of these contracts, which we currently estimate to be approximately 19 years as of October 29, 2022. The balance of these contract assets at January 31, 2022, was $1.3 million, and in the first quarter of the current year, we incurred an additional $0.1 million in contract costs that will be amortized over 19 years. During the three and nine months ended October 29, 2022, we amortized contract costs of $19,000 and $56,000, respectively. The balance of deferred incremental direct costs net of accumulated amortization at October 29, 2022, was $1.4 million, of which $0.1 million is reported in other current assets and $1.3 million is reported in other assets in the accompanying condensed consolidated balance sheet.

Note 5 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards, and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

	Three Months Ended				Nine Months Ended
	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Weighted Average Common Shares Outstanding – Basic		7,324,089		7,234,045		7,299,277		7,196,066
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		55,314		—		63,752		128,437
Weighted Average Common Shares Outstanding – Diluted		7,379,403		7,234,045		7,363,029		7,324,503

For the three and nine months ended October 29, 2022, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of 540,407 and 602,510, respectively. For the three months ended October 30, 2021, the Company had weighted average common stock equivalent shares outstanding of 144,955 that could potentially dilute earnings per share in future periods that were excluded from the computation of diluted net income per share because their effect would have been anti-dilutive given the net loss during the period. For the three and nine months ended October 30, 2021, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of 189,827 and 362,935, respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

10

Note 6 – Intangible Assets

Intangible assets are as follows:

	October 29, 2022										January 31, 2022
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(2,711	)	$	—		$	389	$	3,100	$	(2,515	)	$	—	$	585
RITEC:
Customer Contract Relationships		2,830		(1,606	)		—			1,224		2,830		(1,557	)		—		1,273
TrojanLabel:
Existing Technology		2,327		(2,004	)		59			382		2,327		(1,767	)		127		687
Distributor Relations		937		(565	)		(6	)		366		937		(498	)		46		485
Honeywell:
Customer Contract Relationships		27,243		(11,702	)		—			15,541		27,243		(11,073	)		—		16,170
Astro Machine:
Customer Relationships		1,000		(36	)		—			964
Intangible Assets, net	$	37,437	$	(18,625	)	$	53		$	18,866	$	36,437	$	(17,410	)	$	173	$	19,200

There were no impairments to intangible assets during the periods ended October 29, 2022, and October 30, 2021. With respect to the acquired intangibles included in the table above, amortization expense of $0.4 million has been included in the condensed consolidated statements of income for each of the three month periods ended October 29, 2022, and October 30, 2021. Amortization expense of $1.2 million related to the above-acquired intangibles has been included in the accompanying condensed consolidated statement of income for each of the nine month periods ended October 29, 2022, and October 30, 2021.

Estimated amortization expense for the next five fiscal years is as follows:

(In thousands)	Remaining 2023		2024		2025		2026		2027
Estimated amortization expense	$	429	$	1,778	$	1,138	$	1,138	$	1,138

Note 7 – Inventories

Inventories are stated at the lower of cost (standard and average methods) and net realizable value and include material, labor, and manufacturing overhead. The components of inventories are as follows:

(In thousands)	October 29, 2022			January 31, 2022
Materials and Supplies	$	35,109		$	22,709
Work-In-Process		1,214			1,489
Finished Goods		23,785			19,718
		60,108			43,916
Inventory Reserve		(10,116	)		(9,307	)
	$	49,992		$	34,609

11

Note 8 – Credit Agreement and Debt

In connection with the purchase of Astro Machine, on August 4, 2022, we entered into a Second Amendment to Amended and Restated Credit Agreement (the “Second Amendment”) with Bank of America, N.A., as lender (the “Lender”). The Second Amendment amended the Amended and Restated Credit Agreement dated as of July 30, 2020, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of March 24, 2021, and the LIBOR Transition Amendment, dated as of December 24, 2021 (the “Existing Credit Agreement,” and the Existing Credit Agreement as amended by the Second Amendment, the “Amended Credit Agreement”), between the Company and the Lender.

The Amended Credit Agreement provides for (i) a new term loan in the principal amount of $6.0 million, which term loan was in addition to the existing term loan outstanding under the Existing Credit Agreement in the principal amount of $9.0 million as of the effective date of the Second Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available from $22.5 million to $25.0 million. At the closing of the Second Amendment, we borrowed the entire $6.0 million term loan and $12.4 million under the revolving credit facility, and the proceeds of such borrowings were used in part to pay the purchase price payable under the Purchase Agreement and certain related transaction costs. The revolving credit facility may otherwise be used for corporate purposes.

The Amended Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters over the term of the Amended Credit Agreement on the following repayment schedule: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2022 through July 31, 2023 is $375,000; and the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2023 through April 30, 2027 is $675,000. The entire remaining principal balance of the term loan is required to be paid on August 4, 2027. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than August 4, 2027, and any outstanding revolving loans thereunder will be due and payable in full, and the revolving credit facility will terminate, on such date. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The interest rates under the Amended Credit Agreement are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the Amended Credit Agreement (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.50% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate plus 1.00%, or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.50% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.35% based on our consolidated leverage ratio. The loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

We must comply with various customary financial and non-financial covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio and a minimum consolidated asset coverage ratio. The primary non-financial covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on our or our subsidiaries’ capital stock, to repurchase or acquire our or our subsidiaries’ capital stock, to conduct mergers or acquisitions, to sell assets, to alter our or our subsidiaries’ capital structure, to make investments and loans, to change the nature of our or our subsidiaries’ business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Second Amendment. As of October 29, 2022, we believe we are compliance with all of the covenants in the Credit Agreement.

12

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI ApS, AstroNova GmbH and AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island, and are guaranteed by, and secured by substantially all of the personal property assets of Astro Machine.

Summary of Outstanding Debt

Revolving Credit Facility

During the first nine months of the current year, we borrowed a net of $19.9 million on our revolving line of credit. The balance outstanding under the revolving line of credit bore interest at a weighted average rate of 7.32% and 5.74% for the three and nine months ended October 29, 2022, respectively, and we incurred $341,000 and $409,000 for interest on this obligation during the three and nine months ended October 29, 2022, respectively. Additionally, during the nine months ended October 29, 2022, we incurred $25,000 of commitment fees on the undrawn portion of our revolving credit facility. At October 30, 2021, there was no balance outstanding on the revolving line of credit, and no interest was incurred for the three and nine months ended October 30, 2021. We incurred $38,000 of commitment fees on the undrawn portion of our revolving credit facility for the nine months ended October 30, 2021. Both the interest expense and commitment fees are included as interest expense in the accompanying condensed consolidated income statement for all periods presented. At October 29, 2022, there is $5.1 million remaining available for borrowing under our revolving line of credit.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)	October 29, 2022			January 31, 2022
USD Term Loan (7.75% as of October 29, 2022); maturity date of August 4, 2027	$	14,625		$	—
USD Term Loan (2.35% as of January 31, 2022); maturity date of September 30, 2025		—			9,250
		14,625			9,250
Debt Issuance Costs, net of accumulated amortization		(93	)		(96	)
Current Portion of Term Loans		(1,800	)		(1,000	)
Long-Term Debt	$	12,732		$	8,154

During the three and nine months ended October 29, 2022, we recognized $266,000 and $384,000, respectively, of interest expense on debt. During the three and nine months ended October 30, 2021, we recognized $50,000 and $230,000, respectively, of interest expense on debt. Interest expense is included in the accompanying condensed consolidated income statement for all periods presented.

13

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of October 29, 2022, is as follows:

(In thousands)
Fiscal 2023, remainder	$	375
Fiscal 2024		2,100
Fiscal 2025		2,700
Fiscal 2026		2,700
Fiscal 2027		2,700
Fiscal 2028 and beyond		4,050
	$	14,625

Note 9 – Paycheck Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”).

The PPP Loan, which would have been set to mature on May 6, 2022, was unsecured and bore interest at a rate of 1.0% per annum accruing from the loan date and would have been payable monthly. No payments were due on the PPP Loan until the date on which the lender determined the amount of the PPP Loan that was eligible for forgiveness.

On June 15, 2021, Greenwood notified us that the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on extinguishment of debt in the accompanying condensed consolidated income statement for the nine months ended October 30, 2021.

Note 10 – Derivative Financial Instruments and Risk Management

In 2017, we entered into a cross-currency interest rate swap and an interest rate swap to manage the interest rate risk.

On July 30, 2020, we terminated these two swaps. The terms of the A&R Credit Agreement caused those swaps to cease to be effective hedges of the underlying exposures. The termination of the swaps was contracted immediately prior to the end of the second quarter of fiscal 2021 at a cash cost of approximately $0.7 million which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $58,000 in accumulated other comprehensive loss related to the cross-currency interest rate swap was reclassified into earnings as the forecasted foreign currency interest payments will not occur.

The $0.2 million remaining balance in accumulated other comprehensive loss related to the interest rate swap is being amortized into earnings through the original term of the hedge relationship as the underlying floating interest rate debt still exists.

At October 29, 2022, we have fully reclassified all of the net losses on the frozen OCI balance from accumulated other comprehensive loss to earnings associated with the terminated interest rate swap due to the payment of variable interest associated with the floating interest rate debt.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three and nine months ended October 29, 2022 and October 30, 2021:

	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(19	)	$	(20	)

14

	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(59	)	$	(60	)

Note 11 – Employee Retention Credit

The CARES Act provides an employee retention credit (“ERC”) that was a refundable tax credit against certain employer taxes. On December 27, 2020, Congress enacted the Taxpayer Certainty and Disaster Tax Relief Act of 2020, which amended and extended ERC availability under Section 2301 of the CARES Act. Before the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we were ineligible for the ERC because we received the PPP Loan. Following the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we and other businesses that received loans under that program became retroactively eligible for the ERC.

As a result of the foregoing legislation, we became eligible to claim a refundable tax credit against the employer’s share of Social Security taxes equal to seventy percent (70%) of the qualified wages that we paid to our employees between December 31, 2020 and June 30, 2021. Qualified wages were limited to $10,000 per employee per calendar quarter in 2021 for a maximum ERC per employee of $7,000 per calendar quarter in 2021.

We evaluated our eligibility for the ERC in the second quarter of calendar year 2021. In order to qualify for the ERC, we needed to experience a 20% reduction in gross receipts from either (1) the same quarter in calendar year 2019 or (2) the immediately preceding quarter to the corresponding calendar quarter in 2019. We determined that we qualified for the employee retention credit under the first scenario for wages paid in calendar year 2020 and the first calendar quarter of 2021. In the second quarter of fiscal 2022, we amended certain payroll tax filings and applied for a refund of $3.1 million. Since there is no US GAAP guidance for for-profit business entities that receive government assistance that is not in the form of a loan, an income tax credit or revenue from a contract with a customer, we determined the appropriate accounting treatment by analogy to other guidance. We accounted for the employee retention credit by analogy to International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, of International Financial Reporting Standards (IFRS). Under an IAS 20 analogy, a business entity would recognize the credit on a systematic basis over the periods in which the entity recognizes the payroll expenses for which the grant (i.e., tax credit) is intended to compensate when there is reasonable assurance (i.e., it is probable) that the entity will comply with any conditions attached to the grant and the grant (i.e., tax credit) will be received.

We recorded a $3.1 million receivable in the second quarter of fiscal 2022 for the ERC receivable and recognized a reduction in employer payroll taxes which was allocated to the financial statement captions from which the employee’s taxes were originally incurred. As a result, we recorded a reduction in expenses of $1.7 million in cost of revenue, $0.8 million in selling and marketing, $0.3 million in research and development and $0.3 million in general and administrative in the accompanying condensed consolidated income statement for the nine month period ended October 30, 2021. On March 22, 2022, we received payment of the $3.1 million ERC.

15

Note 12 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement with Honeywell to acquire an exclusive, perpetual, worldwide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years, based on gross revenues from the sales of the printers, paper, and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to mid-double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated after-tax cost of debt for similar companies. As of October 29, 2022, we had paid an aggregate of $9.0 million of the guaranteed minimum royalty obligation. At October 29, 2022, the current portion of the outstanding guaranteed minimum royalty obligation of $1.8 million is to be paid over the next twelve months and is reported as a current liability, and the remainder of $3.3 million is reported as a long-term liability on our condensed consolidated balance sheet. For the three and nine month periods ended October 29, 2022, we incurred $0.3 million and $0.9 million, respectively, in excess royalty expenses which are included in the cost of revenue in our condensed consolidated statements of income. A total of $0.9 million in excess royalties was paid during the current fiscal year, and there are $0.3 million in excess royalty payables due as a result of this agreement for the period ended October 29, 2022.

Note 13 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of one to six years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:

Operating Leases (In thousands)	Balance Sheet Classification		October 29, 2022		January 31, 2022
Lease Assets		Right of Use Assets	$	800	$	1,094
Lease Liabilities – Current		Other Liabilities and Accrued Expenses		291		327
Lease Liabilities – Long Term		Lease Liabilities		550		808

16

Lease cost information is as follows:

			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 29, 2022		October 29, 2022
Operating Lease Costs		General and Administrative Expense	$	115	$	350
			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 30, 2021		October 30, 2021
Operating Lease Costs		General and Administrative Expense	$	125	$	386

Maturities of operating lease liabilities are as follows:

(In thousands)
Fiscal 2023, remaining	$	74
Fiscal 2024		286
Fiscal 2025		186
Fiscal 2026		142
Fiscal 2027		137
Thereafter		85
Total Lease Payments		910
Less: Imputed Interest		(69	)
Total Lease Liabilities	$	841

As of October 29, 2022, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 3.9 years and 3.86%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

17

Supplemental cash flow information related to leases is as follows:

	Three Months Ended		Nine Months Ended
(In thousands)	October 29, 2022		October 29, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	74	$	237
	Three Months Ended		Nine Months Ended
(In thousands)		October 30, 2021		October 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	85	$	285

Note 14 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2022	$	(1,701	)	$	(47	)	$	(1,748	)
Other Comprehensive Loss before reclassification		(1,864	)		—			(1,864	)
Amounts reclassified from AOCL to Earnings		—			47			47
Other Comprehensive Income (Loss)		(1,864	)		47			(1,817	)
Balance at October 29, 2022	$	(3,565	)	$	—		$	(3,565	)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German, Danish and Shanghai subsidiaries.

Note 15 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, canceled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 128,262 unvested RSUs; 128,793 unvested PSUs; 21,172 unvested RSAs and options to purchase an aggregate of 135,500 shares outstanding as of October 29, 2022.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of October 29, 2022, options to purchase an aggregate of 283,274 shares were outstanding under the 2007 Plan and options to purchase an aggregate of 135,325 shares were outstanding under the 2015 Plan.

We also have a Non-Employee Director Annual Compensation Program (the “Program”), under which each of our non-employee directors automatically receives a grant of restricted stock on the date of their re-election to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2023 is $65,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

18

Share-based compensation expense was recognized as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Stock Options	$	—	$	25	$	7	$	187
Restricted Stock Awards and Restricted Stock Units		401		369		963		1,147
Employee Stock Purchase Plan		4		4		7		11
Total	$	405	$	398	$	977	$	1,345

Stock Options

Aggregated information regarding stock option activity for the nine months ended October 29, 2022 is summarized below:

	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2022		598,043		$	14.67
Exercised		(36,444	)		8.41
Forfeited		(5,100	)		15.38
Expired		(2,400	)		8.09
Outstanding at October 29, 2022		554,099		$	15.10

Set forth below is a summary of options outstanding at October 29, 2022:

Outstanding								Exercisable
Range of Exercise prices		Number of Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Options		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$	10.01-15.00		339,549	$	13.62		3.1		339,549	$	13.62		3.1
$	15.01-20.00		214,550	$	17.45		5.1		214,550	$	17.45		5.1
			554,099	$	15.10		3.9		554,099	$	15.10		3.9

There were no stock options granted in either fiscal 2022 or during the nine months ended October 29, 2022, and as of October 29, 2022, there was no unrecognized compensation expense related to stock options.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU and RSA activity for the nine months ended October 29, 2022 is summarized below:

	RSAs & RSUs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2022		220,980		$	12.79
Granted		141,371			12.68
Vested		(83,024	)		13.41
Forfeited		(1,100	)		11.77
Outstanding at October 29, 2022		278,227		$	12.55

As of October 29, 2022, there was approximately $1.9 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.0 years.

19

Employee Stock Purchase Plan

On June 7, 2022, we adopted the AstroNova Inc., 2022 Employee Stock Purchase Plan (“2022 ESPP”) to replace our previous Employee Stock Purchase Plan (the “Prior ESPP”). The 2022 ESPP allows eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 40,000 shares were reserved for issuance under this plan and 2,288 shares were purchased under the 2022 ESSP during the nine month period ended October 29, 2022. During the nine month periods ended October 29, 2022 and October 30, 2021, there were 1,550 and 5,684 shares, respectively, purchased under the Prior ESPP, and no additional purchases may be made under that plan. As of October 29, 2022, 37,712 shares remain available for purchase under the 2022 ESPP.

Note 16 – Income Taxes

Our effective tax rates for the period are as follows:

	Three Months Ended			Nine Months Ended
Fiscal 2023		26.0	%		22.8	%
Fiscal 2022		29.0	%		4.0	%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted pre-tax income and facts known at that time. The estimated annual effective tax rate is applied to the year-to-date pre-tax income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended October 29, 2022, we recognized an income tax expense of $102,000. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings and a $30,000 tax benefit arising from windfall tax benefit related to our stock. During the three months ended October 30, 2021, we recognized an income tax benefit of approximately $174,000. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our third quarter of fiscal 2022.

During the nine months ended October 29, 2022, we recognized an income tax expense of $383,000. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings, a $38,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions, a $51,000 tax benefit arising from a windfall tax benefit related to our stock, and a $13,000 tax expense relating to a revaluation of deferred taxes. During the nine months ended October 30, 2021, we recognized an income tax expense of approximately $297,000. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our third quarter of fiscal 2022, a $1.1 million tax benefit from the forgiveness of the PPP Loan, a $0.1 million tax benefit arising from a windfall tax benefit related to our stock, a $30,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the year, and a $0.3 million tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions. The PPP Loan forgiveness recognized was excluded from taxable income under Section 1106(i) of the CARES Act.

20

Note 17 – Segment Information

We report two segments: Product Identification (“PI”) and Test & Measurement (“T&M”). We evaluate segment performance based on the segment profit (loss) before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021			October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021
Product Identification	$	29,879	$	21,928	$	2,960		$	1,818		$	74,985	$	68,519	$	6,019		$	8,952
T&M		9,526		6,929		1,711			842			27,689		19,261		5,783			2,902
Total	$	39,405	$	28,857		4,671			2,660		$	102,674	$	87,780		11,802			11,854
Corporate Expenses						3,325			2,364							8,456			7,372
Operating Income						1,346			296							3,346			4,482
Other Income (Expense), Net						(955	)		(895	)						(1,665	)		3,002
Income (Loss) Before Income Taxes						391			(599	)						1,681			7,484
Income Tax Provision (Benefit)						102			(174	)						383			297
Net Income (Loss)					$	289		$	(425	)					$	1,298		$	7,187

21

Note 18 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

	October 29, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	14,667	$	14,667	$	14,625

	January 31, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	9,255	$	9,255	$	9,250

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

22

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with our condensed consolidated financial statements included elsewhere herein and our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

We are a multinational enterprise that leverages our proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. We organize our structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. We market and sell our products and services through the following two segments:

• Product Identification (“PI”) – offers color and monochromatic digital label printers, direct-to-package printers and custom OEM printers. PI also provides software to design, manage and print labeling and packaging images locally and across networked printing systems, as well as all related printing supplies such as pressure-sensitive labels, tags, inks, toners and thermal transfer ribbons used by digital printers. PI also provides on-site and remote service, spare parts and various service contracts.

• Test and Measurement (“T&M”) – offers a suite of products and services that acquire data from local and networked data streams and sensors as well as wired and wireless networks. The T&M segment includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft including navigation maps, clearances, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Aerospace products also include aircraft networking systems for high-speed onboard data transfer. T&M also provides repairs, service and spare parts.

We market and sell our products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets. Our growth strategy centers on organic growth through product innovation made possible by research and development initiatives, as well as strategic acquisitions that fit into or complement existing core businesses.

On August 4, 2022, we completed the acquisition of Astro Machine, an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $17.1 million. Astro Machine is reported as part of our Product Identification segment beginning with the third quarter of fiscal 2023. Refer to Note 3, “Acquisition,” in our condensed consolidated financial statements included elsewhere in this report for further details.

23

COVID-19 Update—Overview

All of our global operations have been materially adversely affected by the worldwide COVID-19 pandemic and the related supply-chain disruptions since it began. The full extent and duration of the impact of COVID-19 on our operations and financial performance remains dependent upon the extent and duration of factors such as changes in our customers behavior, the post-pandemic impact of inflation from macroeconomic factors, the impact on our global supply chain, as well as the risk of possible resurgence of COVID-19 (including through variants). We will continue to evaluate the impact of COVID-19 on our business, results of operations and cash flows throughout fiscal 2023, including the potential impacts on various estimates and assumptions inherent in the preparation of the condensed consolidated financial statements.

Since the COVID-19 pandemic began we have experienced difficulties in obtaining raw materials and components for our products. Some of the structural dislocations in the global economy caused by the pandemic are deepening and prolonging these difficulties. We have had to incur additional costs, such as expedited and express shipping fees (i.e., air rather than ocean freight). These difficulties have also negatively impacted our efficiency, delayed shipments, and caused product shortages. We are currently monitoring the worldwide delays in transit time as freight carriers continue to experience significant delays in overseas shipments. We are addressing these issues through long-range planning and procuring higher inventory on severely allocated items to help mitigate potential shortages whenever practicable. We are also monitoring and reacting to extended lead times on electronic components and utilizing a variety of strategies, including blanket orders, vendor-bonded inventories, extended commitments to our supply base, and seeking alternative suppliers. Additionally, we have taken actions to increase regular contact with our essential vendors and increased our forecasting horizon for our products to help us better manage our supply chain. In some cases, we are working with our vendors to help them procure components. Our strategies to counteract the impact of the pandemic and the related supply chain dislocations have significantly increased the amount of inventory we maintain to support our product sales. We have also experienced several situations where component shortages and scarcity have required us to pay significantly higher costs to obtain those components, particularly electronic components and circuit board assemblies. We will continue to monitor our supply chain going forward and update our mitigation strategies as we determine appropriate. We are not able to predict how current supply chain difficulties will develop in the future, and if the steps we are taking are not effective, it could have a material adverse impact on our results of operations.

Product Identification Update

Our Product Identification business has been negatively impacted by the COVID-19 pandemic because our ability to meet with customers to demonstrate our products at trade shows and on-site in their facilities has been curtailed. We have partially countered this through a variety of virtual, online selling and digital marketing strategies. . The degree to which these new strategies and approaches will be successful in mitigating the absence of or reduction in face-to-face selling remains uncertain. More recently, we have attended numerous trade shows, but revised practices have been implemented due to the COVID-19 pandemic.

Test & Measurement Update

The aerospace industry, which we serve through our aerospace product line, has also been significantly disrupted by the COVID-19 pandemic, both inside and outside of the United States because of the severe decline in the demand for air travel and aircraft and a general curtailment of aircraft production rates. This has had a material adverse impact on our financial results. While air travel demand appears to have substantially recovered, it remains unclear whether and to what extent recent aircraft production demand increases will continue. The secondary impacts of the demand decline and resulting financial losses on the economic structure of the airline industry could become a negative factor for demand for aircraft due to industry consolidation. Individually or in combination, these factors may continue to have a material adverse impact on our business operations and financial results.

24

Results of Operations

Three Months Ended October 29, 2022 vs. Three Months Ended October 30, 2021

Revenue by segment and current quarter percentage change over the prior year for the three months ended October 29, 2022 and October 30, 2021 were:

(Dollars in thousands)	October 29, 2022		As a % of Revenue			October 30, 2021		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	29,879		75.8	%	$	21,928		76.0	%		36.3	%
T&M		9,526		24.2	%		6,929		24.0	%		37.5	%
Total	$	39,405		100.0	%	$	28,857		100.0	%		36.6	%

Revenue for the current quarter was $39.4 million, representing a 36.3% increase compared to the prior year’s third quarter revenue of $28.9 million. Revenue through domestic channels for the third quarter of the current year was $26.8 million, an increase of 55.1% from the prior year’s third quarter. International revenue for the third quarter of the current year was $12.6 million, representing 32.0% of our third quarter revenue and reflecting an 8.8% increase from the previous year’s third quarter. Current year’s third quarter international revenue includes an unfavorable foreign exchange rate impact of $1.3 million.

Hardware revenue in the current quarter was $11.9 million, a 56.7% increase compared to the prior year’s third quarter revenue of $7.6 million. The increase in the PI segment hardware revenue of 76.7% compared to the prior year’s third quarter, was a result of the inclusion of hardware revenue attributable to Astro Machine, and the increase in overall T&M segment hardware revenue of 41.0% compared to the prior year’s third quarter was due to increased sales in both the aerospace printer and data recorder product lines.

Supplies revenue in the current quarter was $22.9 million, a 27.1% increase compared to the prior year’s third quarter supplies revenue of $18.1 million. The increase in the current quarter is primarily attributable to higher ink jet supply sales in the PI segment, with the majority of the increase resulting from ink jet supply sales in the newly acquired Astro Machine.

Service and other revenues of $4.5 million in the current quarter increased 41.9% compared to third quarter revenue of $3.2 million in the prior year. The increase is due primarily to increased part sales and repair revenue related to the aerospace printer product line in the T&M segment, as well as a significant contribution of part sales in the PI segment attributable to the newly acquired Astro Machine.

The current year’s third quarter gross profit was $12.5 million, a 20.2% increase compared to the prior year’s third quarter gross profit of $10.4 million. Our current quarter gross profit margin of 31.7% reflects a 4.3 percentage point decrease from the prior year’s third quarter gross profit margin of 36.0%. The lower gross profit margin for the current quarter compared to the prior year’s third quarter is primarily attributable to increased manufacturing and period costs, adverse product mix in both segments, and the mix impact of Astro Machine’s lower gross margins.

Operating expenses for the current quarter were $11.1 million, a 10.4% increase compared to the prior year’s third quarter operating expenses of $10.1 million. Specifically, current quarter selling and marketing expenses were $5.9 million, a 2.3.% increase compared to the third quarter of the prior year. The increase in the current quarter’s selling and marketing expenses was primarily due to an increase in travel and entertainment expenses, outside services, and employee commissions, which were partially offset by a decrease in employee benefits and advertising and trade show expenses. Current quarter general and administrative expenses were $3.3 million, a 40.7% increase compared to the third quarter of the prior year. The increase in general and administrative expenses for the current quarter was primarily due to $0.7 million in transaction costs related to the acquisition of Astro Machine and an increase in employee wages. This increase was partially offset by a decrease in professional fees and advertising and trade show expenses. Research and development (“R&D”) expenses were $1.9 million in the current quarter, a 2.3% decrease compared to the third quarter of the prior year. The current quarter decrease is primarily due to lower supplies and repairs and outside service expenses. R&D spending as a percentage of revenue for the current quarter is 4.8% compared to 6.8% for the same period of the prior year.

25

Other expense in the third quarter of the current year was $1.0 million compared to $0.9 million in the third quarter of the prior year. Current quarter other expense includes interest expense on our term debt and line of credit of $0.7 million and a net foreign exchange loss of $0.2 million and other expense of $0.1 million. Other income for the third quarter of the prior year included $0.7 million related to the write-off of our Oracle EnterpriseOne enterprise resource planning (“ERP”) system and related prepaid service and maintenance contracts as a result of the full implementation of our new global ERP system, interest expense on our term debt of $0.1 million, and a net foreign exchange loss of $0.1 million.

The provision for federal, state and foreign income taxes for the third quarter of the current year is $0.1 million, resulting in an effective tax rate of 26.0%. This compares to the prior year’s third quarter tax benefit of $0.2 million, resulting in an effective tax rate of 29.0%.

We reported net income of $0.3 million or $0.04 per diluted share for the third quarter of the current year. Current quarter results were impacted by transaction costs of $0.7 million ($0.5 million net of tax or $0.07 per diluted share) related to the acquisition of Astro Machine. After taking into consideration these transaction expense and interest expense of $0.3 million attributable to the debt incurred to acquire Astro Machine, the impact of the Astro Machine acquisition on consolidated pre-tax net income was slightly positive. Net loss for the prior year’s third quarter was $0.4 million or $0.06 per diluted share. Prior year third quarter results were impacted by expense of $0.7 million ($0.5 million net of tax or $0.07 per diluted share) related to the write-off of the Oracle EnterpriseOne ERP system and related prepaid service and maintenance contracts. Return on revenue was 0.7% for the current quarter of fiscal 2023 compared to negative 1.5% for the prior year’s third quarter.

Nine Months Ended October 29, 2022 vs. Nine Months Ended October 30, 2021

Revenue by segment and current period percentage change over the prior year for the nine months ended October 29, 2022 and October 30, 2021 were:

(Dollars in thousands)	October 29, 2022		As a % of Revenue			October 30, 2021		As a % of Revenue			% Change Compared to Prior Year
Product Identification	$	74,985		73.0	%	$	68,519		78.1	%		9.4	%
T&M		27,689		27.0	%		19,261		21.9	%		43.8	%
Total	$	102,674		100.0	%	$	87,780		100.0	%		17.0	%

Revenue for the first nine months of the current year was $102.7 million, representing a 17.0% increase compared to the previous year’s first nine months of revenue. Revenue through domestic channels for the first nine months of the current year was $65.5 million, an increase of 28.0% from prior year’s domestic revenue of $51.2 million. International revenue for the first nine months of the current year was $37.2 million, a 1.5% increase from the previous year’s international revenue of $36.6 million. International revenue for the first nine months of the current year reflected an unfavorable foreign exchange rate impact of $2.9 million.

Hardware revenue in the first nine months of the current year was $29.9 million, a 29.1% increase compared to the prior year’s first nine months of hardware revenue of $23.1 million. The increase in hardware revenue is primarily due to a 43.9% increase in hardware sales in the T&M segment primarily attributable to higher aerospace printer product line sales. The PI segment also contributed to the third quarter increase with an overall 13.2% increase in hardware revenue compared to the first nine months of the prior year, as a result of the inclusion of the hardware revenue of Astro Machine, the recent acquisition.

Supplies revenue in the first half of the current year was $60.1 million, representing a 9.3% increase over the prior year’s first nine months supplies revenue of $54.9 million. The increase in the current year’s supplies revenue is primarily attributable to the higher ink jet supply sales in the PI segment with a significant majority of the increase resulting from ink jet supply sales in the newly acquired Astro Machine, partially offset by an overall decline in sales of thermal film supplies.

Service and other revenues were $12.7 million in the first nine months of the current year, a 31.4% increase compared to the prior year’s first nine months service and other revenues of $9.7 million. The increase is due primarily to overall increased repair and parts revenue in the T&M segment.

26

The current year’s first nine months gross profit was $34.6 million, a 1.8% increase from the prior year’s first nine months gross profit of $34.0 million. Our gross profit margin of 33.7% in the current year reflects a 5.0 percentage point decrease from the prior year’s first nine months gross profit margin of 38.7%. The lower gross profit margin for the current year compared to the prior year is primarily attributable to increased manufacturing and period costs and the impact of the ERC, which reduced manufacturing payroll taxes, a component of cost of revenue, in the amount of $1.7 million in the second quarter of the prior year. Gross profit margin was also reduced by the mix impact of Astro Machine’s lower gross profit margins.

Operating expenses for the first nine months of the current fiscal year were $31.2 million, a 5.9% increase compared to the prior year’s first nine months operating expenses of $29.5 million. Selling and marketing expenses for the current year of $17.8 million increased by 5.0% compared to the previous year’s first nine months primarily due to a decrease in payroll taxes in the second quarter of the prior year related to the ERC, which reduced payroll taxes in the amount of $0.8 million, as well as the current year increase in employee wages and benefits and travel and entertainment expense. The current year increase in selling and marketing expenses was partially offset by a decrease in employee bonuses and amortization expenses. General and administrative expenses increased 14.7% to $8.5 million in the first nine months of the current year compared to $7.4 million in the first nine months of the prior year, primarily due to increased outside service expenses, and an increase in payroll taxes related to the ERC, which reduced payroll taxes in the amount of $0.3 million in the second quarter of the prior year. Also contributing to the current year increase was an increase in depreciation expense, partially offset by a decrease in employee bonuses, share based compensation and advertising expenses. R&D expensein the first nine months of the current year was $5.0 million, a 3.5% decrease compared to the prior year’s first nine months R&D expense of $5.2 million. The decrease was primarily due to alower employee bonuses, share based compensation and supplies expenses partially offset by increases in employee wages and benefits, outside consulting fees and the impact of the ERC, which reduced manufacturing payroll taxes in the amount of $0.3 million in the third quarter of the prior year. Current year spending on R&D represents 4.9% of revenue compared to 5.9% in the prior year’s first nine months.

Other expense during the first nine months of the current year was $1.7 million compared to other income of $3.0 million in the first nine months of the previous year. Current year other expense includes interest expense on our term debt and line of credit of $1.1 million and net foreign exchange loss of $0.6 million. Other income for the first nine months of the prior year includes $4.5 million related to the forgiveness of our PPP Loan, partially offset by $0.7 million related to the write-off of our Oracle EnterpriseOne ERP system and related prepaid service and maintenance contracts in anticipation of the full implementation of our new global ERP system, interest expense on our term debt of $0.5 million, net foreign exchange loss of $0.2 million and other expense of $0.1 million.

We recognized $0.4 million of income tax expense for the first nine months of the current fiscal year, resulting in an effective tax rate of 22.8%. We recognized $0.3 million of income tax expense for the first nine months of the prior fiscal year, which reflects a $1.1 million tax benefit from the forgiveness of our PPP Loan, and resulted in a 4.0% effective tax rate.

We reported net income of $1.3 million, or $0.18 per diluted share, for the first nine months of the current year. Current quarter results were impacted by transaction costs of $0.7 million ($0.5 million net of tax or $0.07 per diluted share) related to the acquisition of Astro Machine. Net income for the prior year’s first nine months was $7.2 million, or $0.98 per diluted share. The results for the prior period were impacted by income of $4.5 million ($4.4 million net of tax or $0.61 per diluted share) related to the forgiveness of our PPP Loan, income of $3.1 million ($2.4 million net of tax or $0.33 per diluted share) related to the ERC and expense of $0.7 million ($0.5 million net of tax or $0.07 per diluted share) related to the write-off of the Oracle EnterpriseOne ERP system and related prepaid service and maintenance contracts. Return on revenue was 1.3% for the first nine months of fiscal 2023 compared to 8.2% for the first nine months of fiscal 2022.

27

Segment Analysis

We report two segments: Product Identification and Test & Measurement and evaluate segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021			October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021
Product Identification	$	29,879	$	21,928	$	2,960		$	1,818		$	74,985	$	68,519	$	6,019		$	8,952
T&M		9,526		6,929		1,711			842			27,689		19,261		5,783			2,902
Total	$	39,405	$	28,857		4,671			2,660		$	102,674	$	87,780		11,802			11,854
Corporate Expenses						3,325			2,364							8,456			7,372
Operating Income						1,346			296							3,346			4,482
Other Income (Expense), Net						(955	)		(895	)						(1,665	)		3,002
Income (Loss) Before Income Taxes						391			(599	)						1,681			7,484
Income Tax Provision (Benefit)						102			(174	)						383			297
Net Income (Loss)					$	289		$	(425	)					$	1,298		$	7,187

Product Identification

Revenue from the Product Identification segment increased 36.3% in the third quarter of the current year, with revenue of $29.9 million compared to $21.9 million in the same period of the prior year. The increase in current quarter revenue is primarily due to supply sales which increased $4.9 million or 28.8% compared to the same period in the prior year. Also contributing to the current quarter increase were printer sales, which increased $2.6 million or 76.7% compared to the same period in the prior year, and to a lesser extent, service and other revenue which increased $0.4 million or 31.1% as compared to the third quarter of fiscal 2022. The increase in the components of revenue for the current quarter was attributable to the newly acquired Astro Machine, and organic growth in inkjet supply sales. The increase in current year revenue was partially offset by a small decline in organic service and other revenues. Product Identification’s current quarter segment operating profit was $3.0 million, reflecting a profit margin of 9.9% compared to the prior year’s third quarter segment profit of $1.8 million and related profit margin of 8.3%. The primary reason for the increase in operating margin is due to increased sales and the contribution of profit margin from the newly acquired Astro Machine. The increase in operating margin for the current quarter was partially offset by higher manufacturing and period costs related to higher labor and supply chain costs, higher trade show and travel expenses, increased expense provisions for printers used for product demonstrations, and higher warranty and service charges related to mitigating defective ink damage to some of our installed printers.

Revenue from the Product Identification segment increased 9.4% to $75.0 million in the first nine months of the current year from $68.5 million in the same period of the prior year. The current year’s increase is primarily due to supply sales which increased $4.8 million or 9.0% compared to the same period in the prior year. Also contributing to the current year’s increase were printer sales, which increased $1.5 million or 13.2% compared to the same period in the prior year , and to a lesser extent, service and other revenue which increased $0.2 million or 4.5% as compared to the same period for fiscal 2022. The increase in the components of revenue for the current year was attributable to Astro Machine and organic growth in inkjet supply sales. The increase in current year revenue was partially offset by an overall decline in organic sales of printers and service and other revenues. Product Identification’s current year segment operating profit was $6.0 million with a profit margin of 8.0%, compared to the prior year’s segment operating profit of $9.0 million and related profit margin of 13.1 %. The primary reason for the decline in operating margin is that the same period for the prior year included $1.4 million in net ERC-related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the current year’s third quarter segment operating margin was also lower due to a slightly unfavorable sales mix, the effect on manufacturing and period costs related to higher labor and supply chain costs, higher trade show and travel expenses, increased expense provisions for printers used for product demonstrations, and higher warranty and service charges related to mitigating defective ink damage to some of our installed printers. The decrease in operating profit margin was partially offset by the contribution of profit margin from the newly acquired Astro Machine.

28

Test & Measurement—T&M

Revenue from the T&M segment was $9.5 million for the third quarter of the current fiscal year, representing a 37.5% increase compared to revenue of $6.9 million for the same period in the prior year. The increase in revenue for the current quarter was primarily attributable to increased sales of aerospace cockpit printers and T&M data recorders sales, as well as, the increases in the volume of aerospace product group repairs and parts revenue. These increases are due to the rebound in air travel as the impact of COVID-19 lessens and increased demand for new aircraft. T&M’s third quarter segment operating profit was $1.7 million, reflecting a profit margin of 18.0%, compared to the prior year’s segment operating profit of $0.8 million and related operating margin of 12.2%. The increase in segment operating profit was a result of the impact on gross margins of increased operating leverage on higher revenues and a much more favorable mix of higher-margin parts and repair revenues. However, these favorable impacts were significantly offset by considerably higher component costs in certain aerospace printer models and the adverse effect of relatively higher sales of lower-margin products.

Revenue from the T&M segment was $27.7 million for the first nine months of the current fiscal year, a 43.8% increase compared to sales of $19.3 million for the same period in the prior year. The increase in revenue for the current year was primarily attributable to higher cockpit printer revenue, significantly higher volume of aerospace product group repairs and increased parts revenue, and to a lesser extent, increased hardware sales in the T&M data acquisition product line. These increases are due to the rebound in air travel as the impact of COVID-19 lessens and increased demand for new aircraft. The segment’s first nine months operating profit of $5.8 million resulted in a 20.9% profit margin compared to the prior year’s segment operating profit of $2.9 million and related operating margin of 15.1%. The prior year’s operating profit included the impact of $0.8 million in net ERC-related payroll tax credits that reduced manufacturing and operating costs. Excluding the impact of the ERC, the increase in segment operating profit and margin was a result of slightly lower R&D costs, the impact on gross margins of increased operating leverage on higher revenues, and a much more favorable mix of higher margin parts and repair revenues. However, these favorable impacts were negatively offset by considerably higher component costs in certain aerospace printer models and the adverse effect of relatively higher sales of lower-margin products.

Financial Condition, Liquidity and Capital Resources

Overview

Historically, our primary sources of short-term liquidity have been cash generated from operating activities and borrowings under our revolving credit facility. These sources have also usually funded the majority of our capital expenditures and contractual contingent consideration obligations. We have funded acquisitions by borrowing under bank loan facilities.

29

In connection with our purchase of Astro Machine, on August 4, 2022, we entered into a Second Amendment to Amended and Restated Credit Agreement (the “Second Amendment”) with Bank of America, N.A., as lender (the “Lender”). The Second Amendment amended the Amended and Restated Credit Agreement dated as of July 30, 2020, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of March 24, 2021, and the LIBOR Transition Amendment, dated as of December 24, 2021 (the “Existing Credit Agreement,” and the Existing Credit Agreement as amended by the Second Amendment, the “Amended Credit Agreement”), between the Company and the Lender.

The Amended Credit Agreement provides for (i) a new term loan in the principal amount of $6.0 million, which term loan was in addition to the existing term loan outstanding under the Existing Credit Agreement in the principal amount of $9.0 million as of the effective date of the Second Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available from $22.5 million to $25.0 million. Under the Amended Credit Agreement, revolving credit loans may continue to be borrowed, at our option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner.

While we expected that as a result of the impact of the COVID-19 pandemic, some of our customers would experience liquidity pressure and be unable to pay us for products on a timely basis, in general, our recent receivables collection experience has been consistent with our historical experience and a significant deterioration in receivables collection has not occurred.

In response to the COVID-19 pandemic and related economic dislocation, we have implemented and will continue to implement a variety of expense reduction and cash preservation initiatives. On April 27, 2020, our board of directors suspended our quarterly cash dividend beginning with the second quarter of our fiscal year 2021.

At October 29, 2022, our cash and cash equivalents were $4.5 million. During the first nine months of the current year, we borrowed a net of $19.9 million on our revolving line of credit, and at October 29, 2022, we had $5.1 million available for borrowing under that facility. We believe that our available cash and credit facilities combined with our cash generated from operations will be sufficient to support our operating requirements including our capital expenditure commitments, notwithstanding recent substantial increases in working capital that have increased borrowing levels. We believe further substantial debt-funded increases in working capital are unlikely to be necessary, but if this is incorrect it could have a material impact on our financial condition especially if we were then unable to restructure our credit facilities.

Indebtedness

Term Loan

The Amended Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters over the term of the Amended Credit Agreement on the following repayment schedule: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2022 through July 31, 2023 is $375,000; and the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2023 through April 30, 2027 is $675,000. The entire remaining principal balance of the term loan is required to be paid on August 4, 2027. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than August 4, 2027, and any outstanding revolving loans thereunder will be due and payable in full, and the revolving credit facility will terminate, on such date. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

The interest rates under the Amended Credit Agreement are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the Amended Credit Agreement (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.50% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate plus 1.00%, or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.50% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.35% based on our consolidated leverage ratio.

30

We must comply with various customary financial and non-financial covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio and a minimum consolidated asset coverage ratio. The primary non-financial covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on our or our subsidiaries’ capital stock, to repurchase or acquire our or our subsidiaries’ capital stock, to conduct mergers or acquisitions, to sell assets, to alter our or our subsidiaries’ capital structure, to make investments and loans, to change the nature of our or our subsidiaries’ business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Second Amendment. As of October 29, 2022, we believe we are compliance with all of the covenants in the Credit Agreement.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI ApS, AstroNova GmbH and AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island, and are guaranteed by, and secured by substantially all of the personal property assets of Astro Machine.

31

PPP Loan

On May 6, 2020, we entered into a Loan Agreement with and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (the “PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020. The terms of the PPP Loan were subsequently revised in accordance with the provisions of the Paycheck Protection Flexibility Act of 2020 (the “PPP Flexibility Act”), which was enacted on June 5, 2020.

The PPP Loan, which would have matured on May 6, 2022, was unsecured and bore interest at a rate of 1.0% per annum, accruing from the loan date. No payments were due on the PPP Loan until the date on which the lender determined the amount of the PPP Loan that is eligible for forgiveness.

On June 15, 2021, Greenwood notified us that the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on the extinguishment of debt in Other Income (Expense) in our condensed consolidated income statement for the nine months ended October 30, 2021.

Cash Flow

Our statements of cash flows for the nine months ended October 29, 2022, and October 30, 2021, are included on page 5 of this report. Net cash used by operating activities was $7.5 million for the first nine months of fiscal 2023 compared to cash provided of $3.8 million for the same period of the previous year. The increase in net cash used by operations for the first nine months of the current year is primarily cash used by working capital, as the combination of changes in accounts receivable, inventory, income taxes payable, accounts payable, and accrued expenses decreased cash by $14.6 million for the first nine months of fiscal 2023, compared to an increase to cash of $0.1 million for the same period in fiscal 2022. The increase in cash used by operations for the first nine months of fiscal 2023 was partially offset by the $3.1 million of ERC receivable received in the first quarter of the current year.

Our accounts receivable balance increased to $21.9 million at the end of the third quarter compared to $17.1 million at year end. Excluding the impact of the Astro Machine acquisition, accounts receivable decreased by $1.9 million from prior year end. Days sales outstanding for the first nine months of fiscal 2023 is 45 days, consistent with prior year end.

32

Our inventory balance was $50.0 million at the end of the third quarter of fiscal 2023, compared to $34.6 million at year end. Excluding the impact of the Astro Machine acquisition, inventory increased by $11.7 million from prior year end. The increase in our inventory balance is primarily due to difficulty in the supply chain environment, including long lead times to obtain components and supplies which has required us to increase our component and supply buffer stock to support the demands of our customers in our PI segment. We have also experienced increased inventory levels related to our T&M products to maintain our targeted inventory levels as a result of increased sales in that segment and part shortage issues. Inventory days on hand increased to 167 days at the end of the current quarter from 156 days at the prior year end. This increase in working capital has been funded in part by borrowings under our credit facilities and has increased our interest expense.

The net cash position at October 29, 2022 was $4.5 million compared to the year end balance of $5.3 million. The decrease in the cash balance includes the impact of cash used from the working capital accounts, as discussed above. Additional cash outflows during the first nine months of fiscal 2023 included cash paid for the Astro Machine acquisition of $17.0 million ($17.1 million purchase price, less cash acquired of $0.1 million), principal payments on the long-term debt and the guaranteed royalty obligation of $0.6 million and $1.5 million, respectively, and cash used to acquire property, plant and equipment of $0.2 million. The current year outflows of cash were partially offset by current year borrowing under the revolving credit facility of $19.9 million and proceeds from long term borrowings of $6.0 million.

Critical Accounting Policies, Estimates and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly re-evaluate these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. There have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial, industry and business conditions; (b) global and domestic economic conditions, including currency exchange rate fluctuations, inflation and geopolitical uncertainty and instability; (c) the impact of the ongoing COVID-19 pandemic on us, our customers, our suppliers and the global economy; (d) declining demand in the test and measurement markets, especially defense and aerospace; (e) our ability to develop and introduce new products and achieve market acceptance of these products; (f) our dependence on contract manufactures and/or single or limited source suppliers; (g) competition in the specialty printer or data acquisition industries; (h) our ability to obtain adequate pricing for our products and control our cost structure; (i) our ability to adequately enforce and protect our intellectual property, defend against assertions of infringement or loss of certain licenses; (j) the risk of incurring liabilities as a result of installed product failures due to design or manufacturing defects (k) the risk of a material security breach of our information technology system or cybersecurity attack impacting our business and our relationship with customers; (l) our ability to attract, develop and retain key employees; (m) economic, political and other risks associated with international sales and operations and the impact of changes in foreign currency exchange rates on the results of operations; (n) changes in tax rates or exposure to additional income tax liabilities; (o) our ability to comply with our current credit agreement or secure alternative financing and to otherwise manage our indebtedness; (p) our ability to successfully integrate and realize the expected benefits from Astro Machine and other acquisitions and realize benefits from divestitures; (q) our ability to maintain adequate self-insurance accruals or insurance coverage for employee health care benefits; (r) our compliance with customer or regulators certifications and our compliance with certain governmental laws and regulations; (s) our significant levels of inventory on hand; and (t) other risks included under “Item 1A-Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

33

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

At October 29, 2022, our total indebtedness included a $14.625 million variable-rate term loan and a $19.9 million revolving line of credit. At October 29, 2022, under the LIBOR Transition Amendment to the Amended Credit Agreement, the term loan and revolving line of credit outstanding bear interest at a BSBY (Bloomberg Short-Term Bank Yield) rate plus a margin that varies between 1.60% and 2.50% based on our consolidated leverage ratio. During fiscal 2023, the interest rate on our variable rate term debt and revolving credit line ranged between 4.1 to 7.75%. The impact on our results of operations of a 100 basis point change in the interest rate on the outstanding balance of our variable-rate debt and revolving credit would range between $0.5 million to $0.7 million annually.

Other than above, during the nine months ended October 29, 2022, there were no other material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended January 31, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

There are no pending or threatened legal proceedings against us that we believe to be material to our financial position or results of operations.

Item 1A. Risk Factors

This section augments and updates certain risk factors disclosed in Item 1A of Part I of our Annual Report on Form 10-K for the year ended January 31, 2022 (the “Annual Report”). We are providing the following information regarding changes that have occurred to the previously disclosed risk factors in our Annual Report on Form 10-K. In addition to the other information in this Quarterly Report on Form 10-Q, all risk factors should be carefully considered in evaluating us and our common stock. Any of these risks, many of which are beyond our control, could materially and adversely affect our financial condition, results of operations or cash flows, or cause our actual results to differ materially from those projected in any forward-looking statements. We may also face other risks and uncertainties that are not presently known, are not currently believed to be material, or are not identified below because they are common to all businesses. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. For more information, see “Forward-Looking Statements” elsewhere in this Quarterly Report.

Other than below, there have been no material updates to the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

34

We face risks related to recession, inflation, stagflation and other economic conditions

Customer demand for our products may be impacted by weak economic conditions, inflation, stagflation, recession, rising interest rates, equity market volatility or other negative economic factors in the U.S. or other nations. For example, under these conditions or expectation of such conditions, our customers may cancel orders, delay purchasing decisions or reduce their use of our services. In addition, these economic conditions could result in higher inventory levels and the possibility of resulting in additional charges from our suppliers if we need to slow production to reduce inventory levels. Further, in the event of a recession or threat of a recession our suppliers, distributors, and other third-party partners may suffer their own financial and economic challenges and as a result they may demand pricing accommodations, delay payment, or become insolvent, which could harm our ability to meet our customer demands or collect revenue or otherwise could harm our business. Similarly, disruptions in financial and/or credit markets may impact our ability to manage normal commercial relationships with our customers, suppliers and creditors and might cause us to not be able to continue to access preferred sources of liquidity when we would like, and our borrowing costs could increase. Thus, if general macroeconomic conditions continue to deteriorate, our business and financial results could adversely affect our business, operating results and financial condition.

In addition, we are also subject to risk from inflation and increasing market prices of certain components, supplies, and raw materials, which are incorporated into our end products or used by our suppliers to manufacture our end products. These components, supplies and other raw materials have from time to time become restricted, or general market factors and conditions have in the past and may in the future affect pricing of such components, supplies and commodities (such as inflation or supply chain constraints).

We have significant inventories on hand.

We maintain a significant amount of inventory, and as a result of recent supply chain disruption, we have further increased the amount of inventory we maintain on-hand to ensure we are able to meet market demand for our products. These increases have been concentrated in label printing machines, and supplies sold by our PI business, as well as in electronic components and assemblies in our T&M business. We maintain allowances for slow-moving and obsolete inventory that we believe are adequate but any significant unanticipated changes in future product demand or market conditions, could have an impact on the value of inventory and adversely affect our business, operating results and financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the third quarter of fiscal 2023, we made the following repurchases of our common stock:

	Total Number of Shares Repurchased			Average Price paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number of Shares That May Be Purchased Under The Plans or Programs
August 1—August 31		120	(a)	$	11.82	(a)		—		—
September 1—September 30		204	(b)	$	11.65	(b)		—		—
October 1—October 31		—		$	—			—		—

(a) An executive of the Company delivered 120 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $11.82 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

(b) An executive of the Company delivered 204 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $11.65 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.

35

Item 6. Exhibits

3A	Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.
3B	By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form 10-K/A for the fiscal year ended January 31, 2008 (File no. 000-13200) and incorporated by reference herein.
10.1	Equity Interest Purchase Agreement, dated as of August 4, 2022, by and among AstroNova, Inc., Astro Machine LLC and GSND Holding Corporation, filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.
10.2	Purchase and Sale Agreement, dated as of August 4, 2022, between Astro Machine LLC and Selak Real Estate Limited Partnership, filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.
10.3	Second Amendment to Amended and Restated Credit Agreement, dated as of August 4, 2022, by and among AstroNova, Inc. and Bank of America, N.A. , filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K, event date August 4, 2022, filed with the SEC on August 9, 2022 and incorporated by reference herein.
31.1	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ASTRONOVA, INC.
	(Registrant)
Date: December 7, 2022	By	/s/ Gregory A. Woods
		Gregory A. Woods,
		President and Chief Executive Officer
		(Principal Executive Officer)
	By	/s/ David S. Smith
		David S. Smith,
		Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

37

EX-31.1

Exhibit 31.1

CERTIFICATION

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Gregory A. Woods certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of AstroNova, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 7, 2022

/s/ Gregory A. Woods

Gregory A. Woods,

President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David S. Smith, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of AstroNova, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 7, 2022

/s/ David S. Smith

David S. Smith,

Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

EX-32.1

Exhibit 32.1

ASTRONOVA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10Q of AstroNova, Inc. (the “Company”) for the period ended October 29, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory A. Woods, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 7, 2022

/s/ Gregory A. Woods

Gregory A. Woods,

President and Chief Executive Officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to AstroNova, Inc. and will be retained by AstroNova, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

ASTRONOVA, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of AstroNova, Inc. (the “Company”) for the period ended October 29, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David S. Smith, Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 7, 2022

/s/ David S. Smith

David S. Smith,

Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to AstroNova, Inc. and will be retained by AstroNova, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares	9 Months Ended
	Oct. 29, 2022	Dec. 05, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 29, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Registrant Name	AstroNova, Inc.
Entity Central Index Key	0000008146
Current Fiscal Year End Date	--01-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Trading Symbol	ALOT
Entity Small Business	true
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	RI
Entity File Number	0-13200
Document Quarterly Report	true
Document Transition Report	false
Entity Tax Identification Number	05-0318215
Entity Address, Address Line One	600 East Greenwich Avenue
Entity Address, City or Town	West Warwick
Entity Address, State or Province	RI
Entity Address, Postal Zip Code	02893
City Area Code	401
Local Phone Number	828-4000
Entity Common Stock, Shares Outstanding		7,349,507

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
CURRENT ASSETS
Cash and Cash Equivalents	$ 4,496	$ 5,276
Accounts Receivable, net	21,919	17,124
Inventories, net	49,992	34,609
Employee Retention Credit Receivable		3,135
Prepaid Expenses and Other Current Assets	4,682	3,634
Total Current Assets	81,089	63,778
Property, Plant and Equipment, net	14,041	11,441
Intangible Assets, net	18,866	19,200
Goodwill	17,885	12,156
Deferred Tax Assets	5,567	5,591
Right of Use Assets	800	1,094
Other Assets	1,581	1,695
TOTAL ASSETS	139,829	114,955
CURRENT LIABILITIES
Accounts Payable	9,644	8,590
Accrued Compensation	2,814	3,512
Other Liabilities and Accrued Expenses	4,006	4,113
Revolving Line of Credit	19,900
Current Liability – Royalty Obligation	1,750	2,000
Current Portion of Long-Term Debt	1,800	1,000
Current Liability – Excess Royalty Payment Due	255	235
Income Taxes Payable	912	323
Deferred Revenue	362	262
Total Current Liabilities	41,443	20,035
NON CURRENT LIABILITIES
Long-Term Debt, net of current portion	12,732	8,154
Royalty Obligation, net of current portion	3,298	4,361
Lease Liabilities, net of current portion	550	808
Income Taxes Payable	399	399
Deferred Tax Liabilities	79	186
TOTAL LIABILITIES	58,501	33,943
SHAREHOLDERS' EQUITY
Common Stock	534	528
Additional Paid-in Capital	60,774	59,692
Retained Earnings	57,812	56,514
Treasury Stock, at Cost	(34,227)	(33,974)
Accumulated Other Comprehensive Loss, net of tax	(3,565)	(1,748)
TOTAL SHAREHOLDERS' EQUITY	81,328	81,012
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 139,829	$ 114,955

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 29, 2022	Jan. 31, 2022
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.05	$ 0.05
Common Stock, Shares Authorized	13,000,000	13,000,000
Common Stock, Shares Issued	10,669,689	10,566,404
Treasury Stock, Shares	3,341,354	3,324,280

XML

Condensed Consolidated Statements of Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Income Statement [Abstract]
Revenue	$ 39,405,000	$ 28,857,000	$ 102,674,000	$ 87,780,000
Cost of Revenue	26,923,000	18,472,000	68,080,000	53,792,000
Gross Profit	12,482,000	10,385,000	34,594,000	33,988,000
Operating Expenses:
Selling and Marketing	5,908,000	5,777,000	17,771,000	16,931,000
Research and Development	1,903,000	1,948,000	5,021,000	5,203,000
General and Administrative	3,325,000	2,364,000	8,456,000	7,372,000
Operating Expenses	11,136,000	10,089,000	31,248,000	29,506,000
Operating Income	1,346,000	296,000	3,346,000	4,482,000
Other Income (Expense), net:
Extinguishment of Debt – PPP Loan	0	0	0	4,466,000
Loss on Disposal of Assets	0	(696,000)	0	(696,000)
Interest Expense	(701,000)	(135,000)	(1,086,000)	(526,000)
Loss on Foreign Currency Transactions	(237,000)	(117,000)	(614,000)	(231,000)
Other, net	(17,000)	53,000	35,000	(11,000)
Other Income (Expense), net	(955,000)	(895,000)	(1,665,000)	3,002,000
Income (Loss) Before Income Taxes	391,000	(599,000)	1,681,000	7,484,000
Income Tax Provision (Benefit)	102,000	(174,000)	383,000	297,000
Net Income (Loss)	$ 289,000	$ (425,000)	$ 1,298,000	$ 7,187,000
Net Income (Loss) per Common Share—Basic:	$ 0.04	$ (0.06)	$ 0.18	$ 1
Net Income (Loss) per Common Share—Diluted:	$ 0.04	$ (0.06)	$ 0.18	$ 0.98
Weighted Average Number of Common Shares Outstanding:
Basic	7,324,089	7,234,045	7,299,277	7,196,066
Diluted	7,379,403	7,234,045	7,363,029	7,324,503

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ 289	$ (425)	$ 1,298	$ 7,187
Other Comprehensive Loss, Net of Taxes:
Foreign Currency Translation Adjustments	(497)	(410)	(1,864)	(839)
Loss from Cash Flow Hedges Reclassified to Income Statement	16	16	47	47
Other Comprehensive Loss	(481)	(394)	(1,817)	(792)
Comprehensive Income (Loss)	$ (192)	$ (819)	$ (519)	$ 6,395

XML

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance at Jan. 31, 2021	$ 74,683	$ 521	$ 58,049	$ 50,085	$ (33,588)	$ (384)
Beginning Balance, Shares at Jan. 31, 2021		10,425,094
Share-Based Compensation	478		478
Employee Option Exercises	52		52
Employee Option Exercises, Shares		5,746
Restricted Stock Awards Vested, net	(208)	$ 3	(3)		(208)
Restricted Stock Awards Vested, net, Shares		48,299
Net Income (Loss)	593			593
Other Comprehensive Loss	(65)					(65)
Ending Balance at May. 01, 2021	75,533	$ 524	58,576	50,678	(33,796)	(449)
Ending Balance, Shares at May. 01, 2021		10,479,139
Beginning Balance at Jan. 31, 2021	74,683	$ 521	58,049	50,085	(33,588)	(384)
Beginning Balance, Shares at Jan. 31, 2021		10,425,094
Net Income (Loss)	7,187
Other Comprehensive Loss	(792)
Ending Balance at Oct. 30, 2021	82,182	$ 528	59,502	57,272	(33,944)	(1,176)
Ending Balance, Shares at Oct. 30, 2021		10,556,891
Beginning Balance at May. 01, 2021	75,533	$ 524	58,576	50,678	(33,796)	(449)
Beginning Balance, Shares at May. 01, 2021		10,479,139
Share-Based Compensation	469		469
Employee Option Exercises	35		35
Employee Option Exercises, Shares		3,211
Restricted Stock Awards Vested, net	(146)	$ 4	(4)		(146)
Restricted Stock Awards Vested, net, Shares		72,125
Net Income (Loss)	7,019			7,019
Other Comprehensive Loss	(333)					(333)
Ending Balance at Jul. 31, 2021	82,577	$ 528	59,076	57,697	(33,942)	(782)
Ending Balance, Shares at Jul. 31, 2021		10,554,475
Share-Based Compensation	399		399
Employee Option Exercises	27		27
Employee Option Exercises, Shares		1,983
Restricted Stock Awards Vested, net	(2)				(2)
Restricted Stock Awards Vested, net, Shares		433
Net Income (Loss)	(425)			(425)
Other Comprehensive Loss	(394)					(394)
Ending Balance at Oct. 30, 2021	82,182	$ 528	59,502	57,272	(33,944)	(1,176)
Ending Balance, Shares at Oct. 30, 2021		10,556,891
Beginning Balance at Jan. 31, 2022	81,012	$ 528	59,692	56,514	(33,974)	(1,748)
Beginning Balance, Shares at Jan. 31, 2022		10,566,404
Share-Based Compensation	337		337
Employee Option Exercises	88	$ 1	87
Employee Option Exercises, Shares		11,164
Restricted Stock Awards Vested, net	(249)	$ 3	(3)		(249)
Restricted Stock Awards Vested, net, Shares		61,513
Net Income (Loss)	425			425
Other Comprehensive Loss	(917)					(917)
Ending Balance at Apr. 30, 2022	80,696	$ 532	60,113	56,939	(34,223)	(2,665)
Ending Balance, Shares at Apr. 30, 2022		10,639,081
Beginning Balance at Jan. 31, 2022	$ 81,012	$ 528	59,692	56,514	(33,974)	(1,748)
Beginning Balance, Shares at Jan. 31, 2022		10,566,404
Employee Option Exercises, Shares	36,444
Net Income (Loss)	$ 1,298
Other Comprehensive Loss	(1,817)					(1,817)
Ending Balance at Oct. 29, 2022	81,328	$ 534	60,774	57,812	(34,227)	(3,565)
Ending Balance, Shares at Oct. 29, 2022		10,669,689
Beginning Balance at Apr. 30, 2022	80,696	$ 532	60,113	56,939	(34,223)	(2,665)
Beginning Balance, Shares at Apr. 30, 2022		10,639,081
Share-Based Compensation	235		235
Restricted Stock Awards Vested, net		$ 1	(1)
Restricted Stock Awards Vested, net, Shares		20,410
Net Income (Loss)	584					584
Other Comprehensive Loss	(419)					(419)
Ending Balance at Jul. 30, 2022	81,096	$ 533	60,347	57,523	(34,223)	(3,084)
Ending Balance, Shares at Jul. 30, 2022		10,659,491
Share-Based Compensation	405		405
Employee Option Exercises	23	$ 1	22
Employee Option Exercises, Shares		9,097
Restricted Stock Awards Vested, net	(4)	$ 0	0		(4)
Restricted Stock Awards Vested, net, Shares		1,101
Net Income (Loss)	289					289
Other Comprehensive Loss	(481)					(481)
Ending Balance at Oct. 29, 2022	$ 81,328	$ 534	$ 60,774	$ 57,812	$ (34,227)	$ (3,565)
Ending Balance, Shares at Oct. 29, 2022		10,669,689

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021
Cash Flows from Operating Activities:
Net Income	$ 1,298	$ 7,187
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:
Depreciation and Amortization	2,621	3,070
Amortization of Debt Issuance Costs	18	38
Share-Based Compensation	977	1,345
Loss on Disposal of Assets	0	696
Gain on Extinguishment of Debt	0	(4,466)
Changes in Assets and Liabilities, net of impact of acquisition:
Accounts Receivable	(1,874)	969
Other Receivable – Employee Retention Credit Receivable	3,135	(3,135)
Inventories	(11,695)	(1,804)
Income Taxes	142	(1,965)
Accounts Payable and Accrued Expenses	(1,207)	2,914
Other	(870)	(1,001)
Net Cash Used Provided (Used) by Operating Activities	(7,455)	3,848
Cash Flows from Investing Activities:
Cash Paid for Astro Machine Acquisition, net of acquired cash	(17,034)
Additions to Property, Plant and Equipment	(222)	(1,507)
Net Cash Used for Investing Activities	(17,256)	(1,507)
Cash Flows from Financing Activities:
Net Cash Proceeds from Employee Stock Option Plans	69	47
Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan	42	67
Net Cash Used for Payment of Taxes Related to Vested Restricted Stock	(253)	(356)
Net Borrowings under Revolving Credit Facility	19,900
Payment of Minimum Guarantee Royalty Obligation	(1,500)	(1,500)
Proceeds from Long-Term Debt Borrowings	6,000	10,000
Payoff of Long-Term Debt	0	(12,576)
Principal Payments of Long-Term Debt	(625)	(563)
Payment of Debt Issuance Costs	(15)	0
Net Cash Provided (Used) by for Financing Activities	23,618	(4,881)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	313	(172)
Net Decrease in Cash and Cash Equivalents	(780)	(2,712)
Cash and Cash Equivalents, Beginning of Period	5,276	11,439
Cash and Cash Equivalents, End of Period	4,496	8,727
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	440	268
Cash Paid During the Period for Income Taxes, Net of Refunds	$ 265	$ 2,243

XML

Business and Basis of Presentation

9 Months Ended

Oct. 29, 2022

Business and Basis Of Presentation [Abstract]

Business and Basis of Presentation

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation industries.

Our business consists of two segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The PI segment includes specialty printing systems and related supplies sold under the QuickLabel®, TrojanLabel®, and GetLabels™ brand names. The T&M segment consists of our line of aerospace products, including flight deck printers, networking hardware, and related accessories as well as test and measurement data acquisition systems sold under the AstroNova® brand name.

PI products sold under the QuickLabel, TrojanLabel and GetLabels brands are used in brand owner and commercial applications to provide product packaging, marketing, tracking, branding, and labeling solutions to a wide array of industries. The PI segment offers a variety of digital color label tabletop printers, direct-to-package printers, high-volume presses, and specialty original equipment manufacturer (“OEM”) printing systems, as well as a wide range of label, tag and flexible packaging material substrates and other supplies, including ink and toner, allowing customers to mark, track, protect and enhance the appearance of their products. In the T&M segment, we have a long history of using our technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers, as well as airborne networking hardware for the aerospace market. In addition, the T&M segment includes data acquisition recorders, sold under the AstroNova brand, to enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. On August 4, 2022, we completed the acquisition of Astro Machine, an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $17.1 million. Astro Machine is reported as part of our Product Identification segment beginning with the third quarter of fiscal 2023. Refer to Note 3, “Acquisition,” in our condensed consolidated financial statements included elsewhere in this report for further details.

Our PI products are sold by direct field salespersons as well as independent dealers and representatives, while our T&M products are sold predominantly through direct sales and manufacturers’ representatives. In the United States, we have factory-trained direct field salespeople located throughout the country specializing in PI products. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, Malaysia, Mexico, Singapore, and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 200 independent dealers and representatives selling and marketing our products in over 60 countries.

Unless otherwise indicated, references to “AstroNova”, “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes, including those that require consideration of forecasted financial information, in the context of the unknown future impacts of the continuing COVID-19 pandemic, using information that is reasonably available to us at this time. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, warranty reserves reserves and the purchase price accounting associated with the acquisition of Astro Machine as further discussed in Note 3 “Acquisition”. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters, including our expectations at the time regarding the duration, scope, and severity of the COVID-19 pandemic. Although conditions have improved in the U.S. in recent months, on October 13, 2022, the US Secretary of Health and Human Services extended the COVID-19 public health emergency declaration through at least January 11, 2023. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year’s financial statements have been reclassified to conform to the current year’s presentation.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

XML

Summary of Significant Accounting Policies Update

9 Months Ended

Oct. 29, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies Update

Note 2 – Summary of Significant Accounting Policies Update

The accounting policies used in preparing the condensed consolidated financial statements in this Form 10-Q are the same as those used in preparing our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022.

Recently Adopted Accounting Pronouncements

No new accounting pronouncements, issued or effective during the first nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

XML

Acquisition

9 Months Ended

Oct. 29, 2022

Business Combinations [Abstract]

Acquisition

Note 3 - Acquisition

On August 4, 2022, we acquired Astro Machine LLC (“Astro Machine”), an Elk Grove Village, Illinois-based manufacturer of printing equipment, including labelers, tabbers, conveyors, and envelope feeders for aggregate consideration of $17.1 million.

The acquisition was accomplished pursuant to an Equity Interest Purchase Agreement dated as of August 4, 2022 (the “Purchase Agreement”) by and among us, GSND Holding Corporation (“GSND”), the parent company of Astro Machine, and Astro Machine. Pursuant to the Purchase Agreement, we purchased 100% of the issued and outstanding equity interests of Astro Machine from GSND for a purchase price of $15.6 million. The acquisition was funded using borrowings under our credit facility. We obtained a representation and warranty insurance policy and placed $300,000 of the purchase price into an escrow account, which pursuant to the terms and conditions of the Purchase Agreement, are our sole recourse for breaches of representations and warranties by GSND. Upon the closing of the transaction, Astro Machine became a wholly owned subsidiary of AstroNova, Inc.

Concurrently with the signing of the Purchase Agreement, our newly acquired subsidiary, Astro Machine, entered into a Purchase and Sale Agreement with Selak Real Estate Limited Partnership (“SRE”), pursuant to which Astro Machine purchased certain real property assets of SRE for a purchase price, paid in cash, of $1.5 million. These real estate assets are comprised of a 34,460 square foot industrial manufacturing building (including offices) on 1.26 acres of land which is Astro Machine’s principal place of business.

This transaction is a business combination and will be accounted for using the acquisition method of accounting prescribed by ASC Topic 805, Business Combinations (“ASC 805”), whereby the results of operations, including the revenues and earnings of Astro Machine, are included in our financial statements from the date of acquisition. The purchase price of Astro Machine will be allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair value based on widely accepted valuation techniques in accordance with ASC Topic 820, Fair Value Measurements, at the acquisition date. Any excess of the purchase price over the fair value of the net identified assets acquired and liabilities assumed will be recorded as goodwill. The process for estimating fair values requires the use of significant estimates, assumptions and judgments, including determining the timing and estimates of future cash flows and developing appropriate discount rates. ASC 805 establishes a measurement period to provide companies with a reasonable amount of time to obtain the information necessary to identify and measure various items in a business combination and cannot extend beyond one year from the acquisition date. We expect to complete the final fair value determination of the assets acquired and liabilities assumed as soon as practicable within the measurement period and in any event not later than one year from the acquisition date.

Total acquisition-related costs to date of $0.7 million are included in the general and administrative expenses in our consolidated statement of income for the nine months ended October 29, 2022.

The preliminary allocation of the purchase price as of October 29, 2022, is as follows:

(In thousands)
Cash	$	91
Accounts Receivable		3,393
Inventory		4,557
Property, Plant and Equipment		3,867
Identifiable Intangible Assets		1,000
Goodwill		6,567
Accounts Payable and Other Current Liabilities		(2,350	)
Total Purchase Price	$	17,125

The amounts above are provisional and are based on information that is currently available. Management believes the information provides a reasonable basis for estimating the fair values of assets acquired and liabilities assumed, but is waiting for additional information necessary to finalize those fair values. Therefore, the provisional measurements of fair value reflected are subject to change and such changes could be significanct. Management anticipates changes to the value of inventory, property, plant and equipment, deferred taxes and identifiable intangible assets as additional information is collected and analyzed and pending the completion of certain appraisals and a valuation report and expects to finalize the valuation and complete the purchase price allocation as soon as practicable but no later than one year from the acquisition.

The following table reflects the preliminary fair value of the acquired identifiable intangible asset and related estimated useful lives:

(In thousands)	Fair Value		Useful Life (Years)
Customer Relations	$	1,000		7

The Customer Relations intangible asset represents the relationships that will be maintained with certain historical customers of Astro Machine. This amount was estimated by our management based upon information known as of the date of filing and is subject to change pending completion of the formal valuation report.

Beginning August 4, 2022, the results of operations for Astro Machine have been included in our statement of income for the three and nine months ended October 29, 2022, and are reported as part of the Product Identification segment.

XML

Revenue Recognition

9 Months Ended

Oct. 29, 2022

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Note 4 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems, and airborne printers and networking hardware used in the flight deck and cabin of military, commercial, and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
United States	$	26,806	$	17,280	$	65,501	$	51,154
Europe		7,341		7,163		22,642		23,588
Canada		2,253		1,724		6,333		4,761
Asia		1,392		1,473		4,118		4,523
Central and South America		1,311		814		3,222		2,569
Other		302		403		858		1,185
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

Major product types:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Hardware	$	11,947	$	7,622	$	29,885	$	23,147
Supplies		22,945		18,055		60,055		54,944
Service and Other		4,513		3,180		12,734		9,689
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time.

Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties. Contract liabilities were $362,000 and $262,000 at October 29, 2022, and January 31, 2022, respectively, and are recorded as deferred revenue in the accompanying condensed consolidated balance sheet. The increase in the deferred revenue balance during the nine months ended October 29, 2022, is due to cash payments received in advance of satisfying performance obligations in the current period, offset by $226,000 of revenue recognized during the period that was included in the deferred revenue balance at January 31, 2022.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized over the remaining useful life of these contracts, which we currently estimate to be approximately 19 years as of October 29, 2022. The balance of these contract assets at January 31, 2022, was $1.3 million, and in the first quarter of the current year, we incurred an additional $0.1 million in contract costs that will be amortized over 19 years. During the three and nine months ended October 29, 2022, we amortized contract costs of $19,000 and $56,000, respectively. The balance of deferred incremental direct costs net of accumulated amortization at October 29, 2022, was $1.4 million, of which $0.1 million is reported in other current assets and $1.3 million is reported in other assets in the accompanying condensed consolidated balance sheet.

XML

Net Income Per Common Share

9 Months Ended

Oct. 29, 2022

Earnings Per Share [Abstract]

Net Income Per Common Share

Note 5 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards, and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

	Three Months Ended				Nine Months Ended
	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Weighted Average Common Shares Outstanding – Basic		7,324,089		7,234,045		7,299,277		7,196,066
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		55,314		—		63,752		128,437
Weighted Average Common Shares Outstanding – Diluted		7,379,403		7,234,045		7,363,029		7,324,503

For the three and nine months ended October 29, 2022, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of 540,407 and 602,510, respectively. For the three months ended October 30, 2021, the Company had weighted average common stock equivalent shares outstanding of 144,955 that could potentially dilute earnings per share in future periods that were excluded from the computation of diluted net income per share because their effect would have been anti-dilutive given the net loss during the period. For the three and nine months ended October 30, 2021, the diluted per share amounts do not reflect weighted average common equivalent shares outstanding of 189,827 and 362,935, respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

XML

Intangible Assets

9 Months Ended

Oct. 29, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 6 – Intangible Assets

Intangible assets are as follows:

	October 29, 2022										January 31, 2022
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(2,711	)	$	—		$	389	$	3,100	$	(2,515	)	$	—	$	585
RITEC:
Customer Contract Relationships		2,830		(1,606	)		—			1,224		2,830		(1,557	)		—		1,273
TrojanLabel:
Existing Technology		2,327		(2,004	)		59			382		2,327		(1,767	)		127		687
Distributor Relations		937		(565	)		(6	)		366		937		(498	)		46		485
Honeywell:
Customer Contract Relationships		27,243		(11,702	)		—			15,541		27,243		(11,073	)		—		16,170
Astro Machine:
Customer Relationships		1,000		(36	)		—			964
Intangible Assets, net	$	37,437	$	(18,625	)	$	53		$	18,866	$	36,437	$	(17,410	)	$	173	$	19,200

There were no impairments to intangible assets during the periods ended October 29, 2022, and October 30, 2021. With respect to the acquired intangibles included in the table above, amortization expense of $0.4 million has been included in the condensed consolidated statements of income for each of the three month periods ended October 29, 2022, and October 30, 2021. Amortization expense of $1.2 million related to the above-acquired intangibles has been included in the accompanying condensed consolidated statement of income for each of the nine month periods ended October 29, 2022, and October 30, 2021.

Estimated amortization expense for the next five fiscal years is as follows:

(In thousands)	Remaining 2023		2024		2025		2026		2027
Estimated amortization expense	$	429	$	1,778	$	1,138	$	1,138	$	1,138

XML

Inventories

9 Months Ended

Oct. 29, 2022

Inventory Disclosure [Abstract]

Inventories

Note 7 – Inventories

Inventories are stated at the lower of cost (standard and average methods) and net realizable value and include material, labor, and manufacturing overhead. The components of inventories are as follows:

(In thousands)	October 29, 2022			January 31, 2022
Materials and Supplies	$	35,109		$	22,709
Work-In-Process		1,214			1,489
Finished Goods		23,785			19,718
		60,108			43,916
Inventory Reserve		(10,116	)		(9,307	)
	$	49,992		$	34,609

XML

Credit Agreement and Debt

9 Months Ended

Oct. 29, 2022

Debt Disclosure [Abstract]

Credit Agreement and Debt

Note 8 – Credit Agreement and Debt

In connection with the purchase of Astro Machine, on August 4, 2022, we entered into a Second Amendment to Amended and Restated Credit Agreement (the “Second Amendment”) with Bank of America, N.A., as lender (the “Lender”). The Second Amendment amended the Amended and Restated Credit Agreement dated as of July 30, 2020, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of March 24, 2021, and the LIBOR Transition Amendment, dated as of December 24, 2021 (the “Existing Credit Agreement,” and the Existing Credit Agreement as amended by the Second Amendment, the “Amended Credit Agreement”), between the Company and the Lender.

The Amended Credit Agreement provides for (i) a new term loan in the principal amount of $6.0 million, which term loan was in addition to the existing term loan outstanding under the Existing Credit Agreement in the principal amount of $9.0 million as of the effective date of the Second Amendment, and (ii) an increase in the aggregate principal amount of the revolving credit facility available from $22.5 million to $25.0 million. At the closing of the Second Amendment, we borrowed the entire $6.0 million term loan and $12.4 million under the revolving credit facility, and the proceeds of such borrowings were used in part to pay the purchase price payable under the Purchase Agreement and certain related transaction costs. The revolving credit facility may otherwise be used for corporate purposes.

The Amended Credit Agreement requires that the term loan be paid in quarterly installments on the last day of each of our fiscal quarters over the term of the Amended Credit Agreement on the following repayment schedule: the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2022 through July 31, 2023 is $375,000; and the principal amount of each quarterly installment required to be paid on the last day of each of our fiscal quarters ending on or about October 31, 2023 through April 30, 2027 is $675,000. The entire remaining principal balance of the term loan is required to be paid on August 4, 2027. We may voluntarily prepay the term loan, in whole or in part, from time to time without premium or penalty (other than customary breakage costs, if applicable). We may repay borrowings under the revolving credit facility at any time without premium or penalty (other than customary breakage costs, if applicable), but in any event no later than August 4, 2027, and any outstanding revolving loans thereunder will be due and payable in full, and the revolving credit facility will terminate, on such date. We may reduce or terminate the revolving line of credit at any time, subject to certain thresholds and conditions, without premium or penalty.

The interest rates under the Amended Credit Agreement are as follows: the term loan and revolving credit loans bear interest at a rate per annum equal to, at our option, either (a) the BSBY Rate as defined in the Amended Credit Agreement (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.60% to 2.50% based on our consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate, (iii) the BSBY Rate plus 1.00%, or (iv) 0.50%, plus a margin that varies within a range of 0.60% to 1.50% based on our consolidated leverage ratio. In addition to certain other fees and expenses that we are required to pay to the Lender, we are required to pay a commitment fee on the undrawn portion of the revolving credit facility that varies within a range of 0.15% and 0.35% based on our consolidated leverage ratio. The loans under the Amended Credit Agreement are subject to certain mandatory prepayments, subject to various exceptions, from (a) net cash proceeds from certain dispositions of property, (b) net cash proceeds from certain issuances of equity, (c) net cash proceeds from certain issuances of additional debt and (d) net cash proceeds from certain extraordinary receipts.

Amounts repaid under the revolving credit facility may be reborrowed, subject to continued compliance with the Amended Credit Agreement. No amount of the term loan that is repaid may be reborrowed.

We must comply with various customary financial and non-financial covenants under the Amended Credit Agreement. The financial covenants under the Amended Credit Agreement consist of a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio and a minimum consolidated asset coverage ratio. The primary non-financial covenants limit our and our subsidiaries’ ability to incur future indebtedness, to place liens on assets, to pay dividends or distributions on our or our subsidiaries’ capital stock, to repurchase or acquire our or our subsidiaries’ capital stock, to conduct mergers or acquisitions, to sell assets, to alter our or our subsidiaries’ capital structure, to make investments and loans, to change the nature of our or our subsidiaries’ business, and to prepay subordinated indebtedness, in each case subject to certain exceptions and thresholds as set forth in the Amended Credit Agreement, certain of which provisions were modified by the Second Amendment. As of October 29, 2022, we believe we are compliance with all of the covenants in the Credit Agreement.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Amended Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following (which are subject, in some cases, to certain grace periods): failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of our covenants or representations under the loan documents, default under any other of our or our subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to us or any of our subsidiaries, a significant unsatisfied judgment against us or any of our subsidiaries, or a change of control.

Our obligations under the Amended Credit Agreement continue to be secured by substantially all of our personal property assets (including a pledge of the equity interests we hold in ANI ApS, AstroNova GmbH and AstroNova SAS), subject to certain exceptions, and by a mortgage on our owned real property in West Warwick, Rhode Island, and are guaranteed by, and secured by substantially all of the personal property assets of Astro Machine.

Summary of Outstanding Debt

Revolving Credit Facility

During the first nine months of the current year, we borrowed a net of $19.9 million on our revolving line of credit. The balance outstanding under the revolving line of credit bore interest at a weighted average rate of 7.32% and 5.74% for the three and nine months ended October 29, 2022, respectively, and we incurred $341,000 and $409,000 for interest on this obligation during the three and nine months ended October 29, 2022, respectively. Additionally, during the nine months ended October 29, 2022, we incurred $25,000 of commitment fees on the undrawn portion of our revolving credit facility. At October 30, 2021, there was no balance outstanding on the revolving line of credit, and no interest was incurred for the three and nine months ended October 30, 2021. We incurred $38,000 of commitment fees on the undrawn portion of our revolving credit facility for the nine months ended October 30, 2021. Both the interest expense and commitment fees are included as interest expense in the accompanying condensed consolidated income statement for all periods presented. At October 29, 2022, there is $5.1 million remaining available for borrowing under our revolving line of credit.

Long-Term Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)	October 29, 2022			January 31, 2022
USD Term Loan (7.75% as of October 29, 2022); maturity date of August 4, 2027	$	14,625		$	—
USD Term Loan (2.35% as of January 31, 2022); maturity date of September 30, 2025		—			9,250
		14,625			9,250
Debt Issuance Costs, net of accumulated amortization		(93	)		(96	)
Current Portion of Term Loans		(1,800	)		(1,000	)
Long-Term Debt	$	12,732		$	8,154

During the three and nine months ended October 29, 2022, we recognized $266,000 and $384,000, respectively, of interest expense on debt. During the three and nine months ended October 30, 2021, we recognized $50,000 and $230,000, respectively, of interest expense on debt. Interest expense is included in the accompanying condensed consolidated income statement for all periods presented.

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of October 29, 2022, is as follows:

(In thousands)
Fiscal 2023, remainder	$	375
Fiscal 2024		2,100
Fiscal 2025		2,700
Fiscal 2026		2,700
Fiscal 2027		2,700
Fiscal 2028 and beyond		4,050
	$	14,625

XML

Paycheck Protection Program Loan

9 Months Ended

Oct. 29, 2022

Debt Disclosure [Abstract]

Paycheck Protection Program Loan

Note 9 – Paycheck Protection Program Loan

On May 6, 2020, we entered into a loan agreement with, and executed a promissory note in favor of Greenwood Credit Union (“Greenwood”) pursuant to which we borrowed $4.4 million (the “PPP Loan”) from Greenwood pursuant to the Paycheck Protection Program (“PPP”) administered by the United States Small Business Administration (the “SBA”) and authorized by the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”).

The PPP Loan, which would have been set to mature on May 6, 2022, was unsecured and bore interest at a rate of 1.0% per annum accruing from the loan date and would have been payable monthly. No payments were due on the PPP Loan until the date on which the lender determined the amount of the PPP Loan that was eligible for forgiveness.

On June 15, 2021, Greenwood notified us that the SBA approved our application for forgiveness of the entire $4.4 million principal balance of our PPP Loan and all accrued interest thereon. As a result, we recorded a $4.5 million gain on extinguishment of debt in the accompanying condensed consolidated income statement for the nine months ended October 30, 2021.

XML

Derivative Financial Instruments and Risk Management

9 Months Ended

Oct. 29, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments and Risk Management

Note 10 – Derivative Financial Instruments and Risk Management

In 2017, we entered into a cross-currency interest rate swap and an interest rate swap to manage the interest rate risk.

On July 30, 2020, we terminated these two swaps. The terms of the A&R Credit Agreement caused those swaps to cease to be effective hedges of the underlying exposures. The termination of the swaps was contracted immediately prior to the end of the second quarter of fiscal 2021 at a cash cost of approximately $0.7 million which was settled in the third quarter of fiscal 2021. Upon termination, the remaining balance of $58,000 in accumulated other comprehensive loss related to the cross-currency interest rate swap was reclassified into earnings as the forecasted foreign currency interest payments will not occur.

The $0.2 million remaining balance in accumulated other comprehensive loss related to the interest rate swap is being amortized into earnings through the original term of the hedge relationship as the underlying floating interest rate debt still exists.

At October 29, 2022, we have fully reclassified all of the net losses on the frozen OCI balance from accumulated other comprehensive loss to earnings associated with the terminated interest rate swap due to the payment of variable interest associated with the floating interest rate debt.

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three and nine months ended October 29, 2022 and October 30, 2021:

	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(19	)	$	(20	)

	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(59	)	$	(60	)

XML

Employee Retention Credit

9 Months Ended

Oct. 29, 2022

Employee Retention Credit Disclosure [Abstract]

Employee Retention Credit

Note 11 – Employee Retention Credit

The CARES Act provides an employee retention credit (“ERC”) that was a refundable tax credit against certain employer taxes. On December 27, 2020, Congress enacted the Taxpayer Certainty and Disaster Tax Relief Act of 2020, which amended and extended ERC availability under Section 2301 of the CARES Act. Before the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we were ineligible for the ERC because we received the PPP Loan. Following the enactment of the Taxpayer Certainty and Disaster Tax Relief Act of 2020, we and other businesses that received loans under that program became retroactively eligible for the ERC.

As a result of the foregoing legislation, we became eligible to claim a refundable tax credit against the employer’s share of Social Security taxes equal to seventy percent (70%) of the qualified wages that we paid to our employees between December 31, 2020 and June 30, 2021. Qualified wages were limited to $10,000 per employee per calendar quarter in 2021 for a maximum ERC per employee of $7,000 per calendar quarter in 2021.

We evaluated our eligibility for the ERC in the second quarter of calendar year 2021. In order to qualify for the ERC, we needed to experience a 20% reduction in gross receipts from either (1) the same quarter in calendar year 2019 or (2) the immediately preceding quarter to the corresponding calendar quarter in 2019. We determined that we qualified for the employee retention credit under the first scenario for wages paid in calendar year 2020 and the first calendar quarter of 2021. In the second quarter of fiscal 2022, we amended certain payroll tax filings and applied for a refund of $3.1 million. Since there is no US GAAP guidance for for-profit business entities that receive government assistance that is not in the form of a loan, an income tax credit or revenue from a contract with a customer, we determined the appropriate accounting treatment by analogy to other guidance. We accounted for the employee retention credit by analogy to International Accounting Standards (IAS) 20, Accounting for Government Grants and Disclosure of Government Assistance, of International Financial Reporting Standards (IFRS). Under an IAS 20 analogy, a business entity would recognize the credit on a systematic basis over the periods in which the entity recognizes the payroll expenses for which the grant (i.e., tax credit) is intended to compensate when there is reasonable assurance (i.e., it is probable) that the entity will comply with any conditions attached to the grant and the grant (i.e., tax credit) will be received.

We recorded a $3.1 million receivable in the second quarter of fiscal 2022 for the ERC receivable and recognized a reduction in employer payroll taxes which was allocated to the financial statement captions from which the employee’s taxes were originally incurred. As a result, we recorded a reduction in expenses of $1.7 million in cost of revenue, $0.8 million in selling and marketing, $0.3 million in research and development and $0.3 million in general and administrative in the accompanying condensed consolidated income statement for the nine month period ended October 30, 2021. On March 22, 2022, we received payment of the $3.1 million ERC.

XML

Royalty Obligation

9 Months Ended

Oct. 29, 2022

Royalty Obligation Disclosure [Abstract]

Royalty Obligation

Note 12 – Royalty Obligation

In fiscal 2018, we entered into an Asset Purchase and License Agreement with Honeywell to acquire an exclusive, perpetual, worldwide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years, based on gross revenues from the sales of the printers, paper, and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned, and product sold or service provided, and range from single-digit to mid-double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated after-tax cost of debt for similar companies. As of October 29, 2022, we had paid an aggregate of $9.0 million of the guaranteed minimum royalty obligation. At October 29, 2022, the current portion of the outstanding guaranteed minimum royalty obligation of $1.8 million is to be paid over the next twelve months and is reported as a current liability, and the remainder of $3.3 million is reported as a long-term liability on our condensed consolidated balance sheet. For the three and nine month periods ended October 29, 2022, we incurred $0.3 million and $0.9 million, respectively, in excess royalty expenses which are included in the cost of revenue in our condensed consolidated statements of income. A total of $0.9 million in excess royalties was paid during the current fiscal year, and there are $0.3 million in excess royalty payables due as a result of this agreement for the period ended October 29, 2022.

XML

Leases

9 Months Ended

Oct. 29, 2022

Leases [Abstract]

Leases

Note 13 – Leases

We enter into lease contracts for certain of our facilities at various locations worldwide. Our leases have remaining lease terms of one to six years, some of which include options to extend the lease term for periods of up to five years when it is reasonably certain that we will exercise such options.

Balance sheet and other information related to our leases is as follows:

Operating Leases (In thousands)	Balance Sheet Classification		October 29, 2022		January 31, 2022
Lease Assets		Right of Use Assets	$	800	$	1,094
Lease Liabilities – Current		Other Liabilities and Accrued Expenses		291		327
Lease Liabilities – Long Term		Lease Liabilities		550		808

Lease cost information is as follows:

			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 29, 2022		October 29, 2022
Operating Lease Costs		General and Administrative Expense	$	115	$	350
			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 30, 2021		October 30, 2021
Operating Lease Costs		General and Administrative Expense	$	125	$	386

Maturities of operating lease liabilities are as follows:

(In thousands)
Fiscal 2023, remaining	$	74
Fiscal 2024		286
Fiscal 2025		186
Fiscal 2026		142
Fiscal 2027		137
Thereafter		85
Total Lease Payments		910
Less: Imputed Interest		(69	)
Total Lease Liabilities	$	841

As of October 29, 2022, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 3.9 years and 3.86%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Supplemental cash flow information related to leases is as follows:

	Three Months Ended		Nine Months Ended
(In thousands)	October 29, 2022		October 29, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	74	$	237
	Three Months Ended		Nine Months Ended
(In thousands)		October 30, 2021		October 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	85	$	285

XML

Accumulated Other Comprehensive Loss

9 Months Ended

Oct. 29, 2022

Equity [Abstract]

Accumulated Other Comprehensive Loss

Note 14 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2022	$	(1,701	)	$	(47	)	$	(1,748	)
Other Comprehensive Loss before reclassification		(1,864	)		—			(1,864	)
Amounts reclassified from AOCL to Earnings		—			47			47
Other Comprehensive Income (Loss)		(1,864	)		47			(1,817	)
Balance at October 29, 2022	$	(3,565	)	$	—		$	(3,565	)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German, Danish and Shanghai subsidiaries.

XML

Share-Based Compensation

9 Months Ended

Oct. 29, 2022

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Note 15 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, canceled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 128,262 unvested RSUs; 128,793 unvested PSUs; 21,172 unvested RSAs and options to purchase an aggregate of 135,500 shares outstanding as of October 29, 2022.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of October 29, 2022, options to purchase an aggregate of 283,274 shares were outstanding under the 2007 Plan and options to purchase an aggregate of 135,325 shares were outstanding under the 2015 Plan.

We also have a Non-Employee Director Annual Compensation Program (the “Program”), under which each of our non-employee directors automatically receives a grant of restricted stock on the date of their re-election to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2023 is $65,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.

Share-based compensation expense was recognized as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Stock Options	$	—	$	25	$	7	$	187
Restricted Stock Awards and Restricted Stock Units		401		369		963		1,147
Employee Stock Purchase Plan		4		4		7		11
Total	$	405	$	398	$	977	$	1,345

Stock Options

Aggregated information regarding stock option activity for the nine months ended October 29, 2022 is summarized below:

	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2022		598,043		$	14.67
Exercised		(36,444	)		8.41
Forfeited		(5,100	)		15.38
Expired		(2,400	)		8.09
Outstanding at October 29, 2022		554,099		$	15.10

Set forth below is a summary of options outstanding at October 29, 2022:

Outstanding								Exercisable
Range of Exercise prices		Number of Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Options		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$	10.01-15.00		339,549	$	13.62		3.1		339,549	$	13.62		3.1
$	15.01-20.00		214,550	$	17.45		5.1		214,550	$	17.45		5.1
			554,099	$	15.10		3.9		554,099	$	15.10		3.9

There were no stock options granted in either fiscal 2022 or during the nine months ended October 29, 2022, and as of October 29, 2022, there was no unrecognized compensation expense related to stock options.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU and RSA activity for the nine months ended October 29, 2022 is summarized below:

	RSAs & RSUs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2022		220,980		$	12.79
Granted		141,371			12.68
Vested		(83,024	)		13.41
Forfeited		(1,100	)		11.77
Outstanding at October 29, 2022		278,227		$	12.55

As of October 29, 2022, there was approximately $1.9 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.0 years.

Employee Stock Purchase Plan

On June 7, 2022, we adopted the AstroNova Inc., 2022 Employee Stock Purchase Plan (“2022 ESPP”) to replace our previous Employee Stock Purchase Plan (the “Prior ESPP”). The 2022 ESPP allows eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 40,000 shares were reserved for issuance under this plan and 2,288 shares were purchased under the 2022 ESSP during the nine month period ended October 29, 2022. During the nine month periods ended October 29, 2022 and October 30, 2021, there were 1,550 and 5,684 shares, respectively, purchased under the Prior ESPP, and no additional purchases may be made under that plan. As of October 29, 2022, 37,712 shares remain available for purchase under the 2022 ESPP.

XML

Income Taxes

9 Months Ended

Oct. 29, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Note 16 – Income Taxes

Our effective tax rates for the period are as follows:

	Three Months Ended			Nine Months Ended
Fiscal 2023		26.0	%		22.8	%
Fiscal 2022		29.0	%		4.0	%

We determine our estimated annual effective tax rate at the end of each interim period based on full-year forecasted pre-tax income and facts known at that time. The estimated annual effective tax rate is applied to the year-to-date pre-tax income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended October 29, 2022, we recognized an income tax expense of $102,000. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings and a $30,000 tax benefit arising from windfall tax benefit related to our stock. During the three months ended October 30, 2021, we recognized an income tax benefit of approximately $174,000. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our third quarter of fiscal 2022.

During the nine months ended October 29, 2022, we recognized an income tax expense of $383,000. The effective tax rate in this period was directly impacted by our jurisdictional mix of earnings, a $38,000 tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions, a $51,000 tax benefit arising from a windfall tax benefit related to our stock, and a $13,000 tax expense relating to a revaluation of deferred taxes. During the nine months ended October 30, 2021, we recognized an income tax expense of approximately $297,000. The effective tax rate in this period was directly impacted by a significant decrease in forecasted operating results for our fiscal 2022 as compared to operating results forecasted at the end of our third quarter of fiscal 2022, a $1.1 million tax benefit from the forgiveness of the PPP Loan, a $0.1 million tax benefit arising from a windfall tax benefit related to our stock, a $30,000 tax benefit related to return to provision adjustments from foreign tax returns filed in the year, and a $0.3 million tax benefit related to the expiration of the statute of limitations on previously uncertain tax positions. The PPP Loan forgiveness recognized was excluded from taxable income under Section 1106(i) of the CARES Act.

XML

Segment Information

9 Months Ended

Oct. 29, 2022

Segment Reporting [Abstract]

Segment Information

Note 17 – Segment Information

We report two segments: Product Identification (“PI”) and Test & Measurement (“T&M”). We evaluate segment performance based on the segment profit (loss) before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021			October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021
Product Identification	$	29,879	$	21,928	$	2,960		$	1,818		$	74,985	$	68,519	$	6,019		$	8,952
T&M		9,526		6,929		1,711			842			27,689		19,261		5,783			2,902
Total	$	39,405	$	28,857		4,671			2,660		$	102,674	$	87,780		11,802			11,854
Corporate Expenses						3,325			2,364							8,456			7,372
Operating Income						1,346			296							3,346			4,482
Other Income (Expense), Net						(955	)		(895	)						(1,665	)		3,002
Income (Loss) Before Income Taxes						391			(599	)						1,681			7,484
Income Tax Provision (Benefit)						102			(174	)						383			297
Net Income (Loss)					$	289		$	(425	)					$	1,298		$	7,187

XML

Fair Value

9 Months Ended

Oct. 29, 2022

Fair Value Disclosures [Abstract]

Fair Value

Note 18 – Fair Value

Assets and Liabilities Not Recorded at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

	October 29, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	14,667	$	14,667	$	14,625

	January 31, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	9,255	$	9,255	$	9,250

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

XML

Summary of Significant Accounting Policies Update (Policies)

9 Months Ended

Oct. 29, 2022

Accounting Policies [Abstract]

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of AstroNova, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

No new accounting pronouncements, issued or effective during the first nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

XML

Acquisition (Tables)

9 Months Ended

Oct. 29, 2022

Business Combinations [Abstract]

Summary of Preliminary Allocation of the Purchase Price

The preliminary allocation of the purchase price as of October 29, 2022, is as follows:

(In thousands)
Cash	$	91
Accounts Receivable		3,393
Inventory		4,557
Property, Plant and Equipment		3,867
Identifiable Intangible Assets		1,000
Goodwill		6,567
Accounts Payable and Other Current Liabilities		(2,350	)
Total Purchase Price	$	17,125

Summary of Preliminary Fair Value of the Acquired Identifiable Intangible Asset

The following table reflects the preliminary fair value of the acquired identifiable intangible asset and related estimated useful lives:

(In thousands)	Fair Value		Useful Life (Years)
Customer Relations	$	1,000		7

XML

Revenue Recognition (Tables)

9 Months Ended

Oct. 29, 2022

Revenue from Contract with Customer [Abstract]

Summary of Revenues Disaggregated by Primary Geographic Markets and Major Product Type

Primary geographical markets:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
United States	$	26,806	$	17,280	$	65,501	$	51,154
Europe		7,341		7,163		22,642		23,588
Canada		2,253		1,724		6,333		4,761
Asia		1,392		1,473		4,118		4,523
Central and South America		1,311		814		3,222		2,569
Other		302		403		858		1,185
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

Major product types:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Hardware	$	11,947	$	7,622	$	29,885	$	23,147
Supplies		22,945		18,055		60,055		54,944
Service and Other		4,513		3,180		12,734		9,689
Total Revenue	$	39,405	$	28,857	$	102,674	$	87,780

XML

Net Income Per Common Share (Tables)

9 Months Ended

Oct. 29, 2022

Earnings Per Share [Abstract]

Summary of Basic and Diluted Net Income Per Share

A reconciliation of the shares used in calculating basic and diluted net income per share is as

	Three Months Ended				Nine Months Ended
	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Weighted Average Common Shares Outstanding – Basic		7,324,089		7,234,045		7,299,277		7,196,066
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		55,314		—		63,752		128,437
Weighted Average Common Shares Outstanding – Diluted		7,379,403		7,234,045		7,363,029		7,324,503

XML

Intangible Assets (Tables)

9 Months Ended

Oct. 29, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

Intangible assets are as follows:

	October 29, 2022										January 31, 2022
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(2,711	)	$	—		$	389	$	3,100	$	(2,515	)	$	—	$	585
RITEC:
Customer Contract Relationships		2,830		(1,606	)		—			1,224		2,830		(1,557	)		—		1,273
TrojanLabel:
Existing Technology		2,327		(2,004	)		59			382		2,327		(1,767	)		127		687
Distributor Relations		937		(565	)		(6	)		366		937		(498	)		46		485
Honeywell:
Customer Contract Relationships		27,243		(11,702	)		—			15,541		27,243		(11,073	)		—		16,170
Astro Machine:
Customer Relationships		1,000		(36	)		—			964
Intangible Assets, net	$	37,437	$	(18,625	)	$	53		$	18,866	$	36,437	$	(17,410	)	$	173	$	19,200

Summary of Estimated Amortization Expense

Estimated amortization expense for the next five fiscal years is as follows:

(In thousands)	Remaining 2023		2024		2025		2026		2027
Estimated amortization expense	$	429	$	1,778	$	1,138	$	1,138	$	1,138

XML

Inventories (Tables)

9 Months Ended

Oct. 29, 2022

Inventory Disclosure [Abstract]

Components of Inventories

Inventories are stated at the lower of cost (standard and average methods) and net realizable value and include material, labor, and manufacturing overhead. The components of inventories are as follows:

(In thousands)	October 29, 2022			January 31, 2022
Materials and Supplies	$	35,109		$	22,709
Work-In-Process		1,214			1,489
Finished Goods		23,785			19,718
		60,108			43,916
Inventory Reserve		(10,116	)		(9,307	)
	$	49,992		$	34,609

XML

Credit Agreement and Debt (Tables)

9 Months Ended

Oct. 29, 2022

Debt Disclosure [Abstract]

Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)	October 29, 2022			January 31, 2022
USD Term Loan (7.75% as of October 29, 2022); maturity date of August 4, 2027	$	14,625		$	—
USD Term Loan (2.35% as of January 31, 2022); maturity date of September 30, 2025		—			9,250
		14,625			9,250
Debt Issuance Costs, net of accumulated amortization		(93	)		(96	)
Current Portion of Term Loans		(1,800	)		(1,000	)
Long-Term Debt	$	12,732		$	8,154

Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of October 29, 2022, is as follows:

(In thousands)
Fiscal 2023, remainder	$	375
Fiscal 2024		2,100
Fiscal 2025		2,700
Fiscal 2026		2,700
Fiscal 2027		2,700
Fiscal 2028 and beyond		4,050
	$	14,625

XML

Derivative Financial Instruments and Risk Management (Tables)

9 Months Ended

Oct. 29, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Impact of the Derivative Instruments in the Condensed Consolidated Financial Statements

The following table presents the impact of our derivative instruments in our condensed consolidated financial statements for the three and nine months ended October 29, 2022 and October 30, 2021:

	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(19	)	$	(20	)

	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income		Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
Cash Flow Hedge (In thousands)	October 29, 2022		October 30, 2021				October 29, 2022			October 30, 2021
Swap contracts	$	—	$	—		Other Expense	$	(59	)	$	(60	)

XML

Leases (Tables)

9 Months Ended

Oct. 29, 2022

Leases [Abstract]

Schedule Of Balance Sheet And Other Information Related To Operating Leases

Balance sheet and other information related to our leases is as follows:

Operating Leases (In thousands)	Balance Sheet Classification		October 29, 2022		January 31, 2022
Lease Assets		Right of Use Assets	$	800	$	1,094
Lease Liabilities – Current		Other Liabilities and Accrued Expenses		291		327
Lease Liabilities – Long Term		Lease Liabilities		550		808

Schedule Lease Cost Information

Lease cost information is as follows:

			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 29, 2022		October 29, 2022
Operating Lease Costs		General and Administrative Expense	$	115	$	350
			Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification		October 30, 2021		October 30, 2021
Operating Lease Costs		General and Administrative Expense	$	125	$	386

Schedule of Maturities Of Lease Liabilities

Maturities of operating lease liabilities are as follows:

(In thousands)
Fiscal 2023, remaining	$	74
Fiscal 2024		286
Fiscal 2025		186
Fiscal 2026		142
Fiscal 2027		137
Thereafter		85
Total Lease Payments		910
Less: Imputed Interest		(69	)
Total Lease Liabilities	$	841

Supplemental Cash Flow Information Related To Leases

Supplemental cash flow information related to leases is as follows:

	Three Months Ended		Nine Months Ended
(In thousands)	October 29, 2022		October 29, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	74	$	237
	Three Months Ended		Nine Months Ended
(In thousands)		October 30, 2021		October 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$	85	$	285

XML

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Oct. 29, 2022

Equity [Abstract]

Changes in Balance of Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2022	$	(1,701	)	$	(47	)	$	(1,748	)
Other Comprehensive Loss before reclassification		(1,864	)		—			(1,864	)
Amounts reclassified from AOCL to Earnings		—			47			47
Other Comprehensive Income (Loss)		(1,864	)		47			(1,817	)
Balance at October 29, 2022	$	(3,565	)	$	—		$	(3,565	)

XML

Share-Based Compensation (Tables)

9 Months Ended

Oct. 29, 2022

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:

	Three Months Ended				Nine Months Ended
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022		October 30, 2021
Stock Options	$	—	$	25	$	7	$	187
Restricted Stock Awards and Restricted Stock Units		401		369		963		1,147
Employee Stock Purchase Plan		4		4		7		11
Total	$	405	$	398	$	977	$	1,345

Aggregated Information Regarding Stock Options Granted

Aggregated information regarding stock option activity for the nine months ended October 29, 2022 is summarized below:

	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2022		598,043		$	14.67
Exercised		(36,444	)		8.41
Forfeited		(5,100	)		15.38
Expired		(2,400	)		8.09
Outstanding at October 29, 2022		554,099		$	15.10

Summary of Options Outstanding

Set forth below is a summary of options outstanding at October 29, 2022:

Outstanding								Exercisable
Range of Exercise prices		Number of Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Options		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$	10.01-15.00		339,549	$	13.62		3.1		339,549	$	13.62		3.1
$	15.01-20.00		214,550	$	17.45		5.1		214,550	$	17.45		5.1
			554,099	$	15.10		3.9		554,099	$	15.10		3.9

Aggregated Information Regarding RSUs and RSAs Granted

Aggregated information regarding RSU and RSA activity for the nine months ended October 29, 2022 is summarized below:

	RSAs & RSUs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2022		220,980		$	12.79
Granted		141,371			12.68
Vested		(83,024	)		13.41
Forfeited		(1,100	)		11.77
Outstanding at October 29, 2022		278,227		$	12.55

XML

Income Taxes (Tables)

9 Months Ended

Oct. 29, 2022

Income Tax Disclosure [Abstract]

Projected Effective Tax Rate for Periods

Our effective tax rates for the period are as follows:

	Three Months Ended			Nine Months Ended
Fiscal 2023		26.0	%		22.8	%
Fiscal 2022		29.0	%		4.0	%

XML

Segment Information (Tables)

9 Months Ended

Oct. 29, 2022

Segment Reporting [Abstract]

Net Sales and Segment Operating Profit (Loss) for Each Reporting Segment

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit (Loss)						Revenue				Segment Operating Profit (Loss)
(In thousands)	October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021			October 29, 2022		October 30, 2021		October 29, 2022			October 30, 2021
Product Identification	$	29,879	$	21,928	$	2,960		$	1,818		$	74,985	$	68,519	$	6,019		$	8,952
T&M		9,526		6,929		1,711			842			27,689		19,261		5,783			2,902
Total	$	39,405	$	28,857		4,671			2,660		$	102,674	$	87,780		11,802			11,854
Corporate Expenses						3,325			2,364							8,456			7,372
Operating Income						1,346			296							3,346			4,482
Other Income (Expense), Net						(955	)		(895	)						(1,665	)		3,002
Income (Loss) Before Income Taxes						391			(599	)						1,681			7,484
Income Tax Provision (Benefit)						102			(174	)						383			297
Net Income (Loss)					$	289		$	(425	)					$	1,298		$	7,187

XML

Fair Value (Tables)

9 Months Ended

Oct. 29, 2022

Fair Value Disclosures [Abstract]

Summary of Financial Assets and Liabilities Measured at Fair Value

Our long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

	October 29, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	14,667	$	14,667	$	14,625

	January 31, 2022
	Fair Value Measurement
(In thousands)	Level 1		Level 2		Level 3		Total		Carrying Value
Long-Term debt and related current maturities	$	—	$	—	$	9,255	$	9,255	$	9,250

The fair value of our long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

XML

Business and Basis of Presentation - Additional Information (Detail) $ in Thousands		9 Months Ended
	Aug. 04, 2022 USD ($)	Oct. 29, 2022 USD ($) Segment
Number of Operating Segments | Segment		2
Business Combination, Consideration Transferred		$ 17,034
Astro Machine LLC [Member]
Business Combination, Consideration Transferred	$ 17,100

XML

Acquisition - Summary of Preliminary Allocation of the Purchase Price (Detail) $ in Thousands	Oct. 29, 2022 USD ($)
Business Acquisition [Line Items]
Cash	$ 91
Accounts Receivable	3,393
Inventory	4,557
Property, Plant and Equipment	3,867
Identifiable Intangible Assets	1,000
Goodwill	6,567
Accounts Payable and Other Current Liabilities	(2,350)
Total Purchase Price	$ 17,125

XML

Acquisition - Summary of Preliminary Fair Value of the Acquired Identifiable Intangible Asset (Detail) - Customer Relationships [Member] $ in Thousands	9 Months Ended
	Oct. 29, 2022 USD ($)
Acquired Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 1,000
Useful Life (Years)	7 years

XML

Acquisition - Additional Information (Detail)		9 Months Ended
	Aug. 04, 2022 USD ($) ft²	Oct. 29, 2022 USD ($)
Business Acquisition [Line Items]
Business Combination, Consideration Transferred		$ 17,034,000
Area of Land | ft²	34,460
Agreement With Astro Machine For Asset Acquisitions [Member]
Business Acquisition [Line Items]
Purchase price of acquisition	$ 15,600,000
Business Combination, Consideration Transferred	$ 17,100,000
Payments to Acquire Businesses, Gross	100.00%
Purchase price into an escrow account	$ 300,000
Payments to Acquire Additional Interest in Subsidiaries	$ 1,500,000
Number of Acres of land		1.26 acres
Agreement With Astro Machine For Asset Acquisitions [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Business Combination, Acquisition Related Costs		$ 700,000

XML

Revenue Recognition - Summary of Revenues Disaggregated by Primary Geographic Markets (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 31, 2021	Oct. 30, 2021
Disaggregation of Revenue [Line Items]
Total Revenue	$ 39,405	$ 28,857	$ 102,674	$ 87,780	$ 87,780
United States [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	26,806	17,280	65,501		51,154
Europe [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	7,341	7,163	22,642		23,588
Canada [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	2,253	1,724	6,333		4,761
Asia [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	1,392	1,473	4,118		4,523
Central and South America [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	1,311	814	3,222		2,569
Other [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	$ 302	$ 403	$ 858		$ 1,185

XML

Revenue Recognition - Summary of Revenues Disaggregated by Primary Product Type (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 31, 2021	Oct. 30, 2021
Disaggregation of Revenue [Line Items]
Total Revenue	$ 39,405	$ 28,857	$ 102,674	$ 87,780	$ 87,780
Hardware [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	11,947	7,622	29,885		23,147
Supplies [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	22,945	18,055	60,055		54,944
Service and Other [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	$ 4,513	$ 3,180	$ 12,734		$ 9,689

XML

Revenue Recognition - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022	Jan. 31, 2022
Contract liabilities and extended warranties	$ 362,000	$ 362,000	$ 262,000
Contract with customer liability revenue recognized including additions	226,000	226,000
Contract assets balance	1,300,000	1,300,000	$ 1,300,000
Additional contract costs	100,000	100,000
Amortization of incremental direct costs	19,000	56,000
Deferred incremental direct contract costs reported in other current assets	100,000	100,000
Capitalized contract cost net long term and short term	$ 1,400,000	$ 1,400,000
Capitalized contract costs additional amounts incurred amortization period		19 years

XML

Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) - shares	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Weighted Average Common Shares Outstanding – Basic	7,324,089	7,234,045	7,299,277	7,196,066
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units	55,314	0	63,752	128,437
Weighted Average Common Shares Outstanding – Diluted	7,379,403	7,234,045	7,363,029	7,324,503

XML

Net Income Per Common Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Number of common equivalent shares	540,407	189,827	602,510	362,935
Common Stock [Member]
Number of common equivalent shares		144,955

XML

Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 37,437	$ 36,437
Accumulated Amortization	(18,625)	(17,410)
Currency Translation Adjustment	53	173
Net Carrying Amount	18,866	19,200
Customer Contract Relationships [Member] | Honeywell Asset Purchase and License Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	27,243	27,243
Accumulated Amortization	(11,702)	(11,073)
Net Carrying Amount	15,541	16,170
Customer Contract Relationships [Member] | Miltope [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,100	3,100
Accumulated Amortization	(2,711)	(2,515)
Net Carrying Amount	389	585
Customer Contract Relationships [Member] | RITEC [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,830	2,830
Accumulated Amortization	(1,606)	(1,557)
Net Carrying Amount	1,224	1,273
Existing Technology [Member] | TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,327	2,327
Accumulated Amortization	(2,004)	(1,767)
Currency Translation Adjustment	59	127
Net Carrying Amount	382	687
Distributor Relations [Member] | TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	937	937
Accumulated Amortization	(565)	(498)
Currency Translation Adjustment	(6)	46
Net Carrying Amount	366	$ 485
Customer Relationships [Member] | Agreement With Astro Machine For Asset Acquisitions [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,000
Accumulated Amortization	(36)
Net Carrying Amount	$ 964

XML

Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 31, 2021	Oct. 30, 2021
Intangible Assets [Line Items]
Impairments of intangible assets			$ 0		$ 0
Amortization expense	$ 400	$ 400	$ 1,200	$ 1,200

XML

Intangible Assets - Summary of Estimated Amortization Expense (Detail) $ in Thousands	Oct. 29, 2022 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remaining 2023	$ 429
2024	1,778
2025	1,138
2026	1,138
2027	$ 1,138

XML

Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
Inventory Disclosure [Abstract]
Materials and Supplies	$ 35,109	$ 22,709
Work-In-Process	1,214	1,489
Finished Goods	23,785	19,718
Inventory, Gross	60,108	43,916
Inventory Reserve	(10,116)	(9,307)
Inventories	$ 49,992	$ 34,609

XML

Credit Agreement and Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
Debt Instrument [Line Items]
USD Term Loan	$ 14,625	$ 9,250
Debt Issuance Costs, net of accumulated amortization	(93)	(96)
Current Portion of Term Loans	(1,800)	(1,000)
Long-Term Debt	12,732	8,154
Term Loan Due September 30, 2025 [Member]
Debt Instrument [Line Items]
USD Term Loan	0	9,250
Term Loan Due August 4, 2027 [Member]
Debt Instrument [Line Items]
USD Term Loan	$ 14,625	$ 0

XML

Credit Agreement and Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) - Term Loan [Member] $ in Thousands	Oct. 29, 2022 USD ($)
Debt Instrument [Line Items]
Fiscal 2023, remainder	$ 375
Fiscal 2024	2,100
Fiscal 2025	2,700
Fiscal 2026	2,700
Fiscal 2027	2,700
Fiscal 2028 and beyond	4,050
Long-term Debt	$ 14,625

XML

Credit Agreement and Debt - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended				42 Months Ended
	Aug. 04, 2022	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2021	Jul. 31, 2023	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2021	Apr. 30, 2027
Debt Instrument [Line Items]
Revolving loan outstanding		$ 19,900		$ 0		$ 19,900		$ 0
Interest Expense, Debt		266,000	$ 50,000			384,000	$ 230,000
Proceeds from long term line of credit						$ 19,900
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Variable interest rate						0.50
LIBOR [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate						1.00%
Federal Funds Effective Swap Rate [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate						0.50%
Minimum [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Commitment fee rate						0.15%
Percentage added to variable rate						0.60%
Minimum [Member] | LIBOR [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate						1.60%
Maximum [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Commitment fee rate						0.35%
Percentage added to variable rate						1.50%
Maximum [Member] | LIBOR [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate						2.50%
Bank of America, N.A. [Member] | Term Loan [Member]
Debt Instrument [Line Items]
Debt Instrument, principal Periodic payment					$ 375,000				$ 675,000
Bank of America, N.A. [Member] | Term Loan [Member] | Additional Term Loan Availed [Member] | Second Amendment Credit Agreement [Member]
Debt Instrument [Line Items]
Principal amount of debt	$ 6,000
Bank of America, N.A. [Member] | Term Loan [Member] | Before Amendement To The Credit Agreement [Member]
Debt Instrument [Line Items]
Principal amount of debt		9,000				$ 9,000
Bank of America, N.A. [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity		$ 5,100				$ 5,100
Long term debt weighted average interest rate over a period of time		7.32%				5.74%
Bank of America, N.A. [Member] | Revolving Credit Facility [Member] | Second Amendment Credit Agreement [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	25,000
Proceeds from long term line of credit	$ 12,400					$ 6,000
Bank of America, N.A. [Member] | Revolving Credit Facility [Member] | Before Amendement To The Credit Agreement [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 22,500				22,500
Bank of America, N.A. [Member] | Revolving Credit Facility [Member] | Other Expense [Member]
Debt Instrument [Line Items]
Interest Expense, Debt		$ 341,000		$ 0		409,000		0
Line of Credit Facility, Commitment Fee Amount						$ 25,000		$ 38,000

XML

Paycheck Protection Program Loan - Additional information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	May 06, 2020
Extinguishment of Debt – PPP Loan	$ 0	$ 0	$ 0	$ 4,466
Paycheck Protection Program Loan [Member] | Green wood Credit Union [Member]
Debt instrument face amount					$ 4,400
Loan, payment terms			The PPP Loan, which would have been set to mature on May 6, 2022, was unsecured and bore interest at a rate of 1.0% per annum accruing from the loan date
Loan, maturity date			May 06, 2022
Loan, interest rate	1.00%		1.00%
Loan, payments due			$ 0
Amount of PPP loan forgiven			4,400
Extinguishment of Debt – PPP Loan			$ 4,500

XML

Derivative Financial Instruments and Risk Management - Additional Information (Detail) - USD ($)		3 Months Ended
	Jul. 30, 2020	Oct. 30, 2021
Cash Flow Hedging [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash paid termination of swaps		$ 700,000
Cross Currency Interest Rate Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Swap Termination	$ 200,000
Cross Currency Interest Rate Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Reclassified from Accumulated OCI into Income (Expense)		$ 58,000

XML

Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instruments in the Condensed Consolidated Financial Statements (Detail) - Cash Flow Hedge [Member] - Cross Currency Interest Rate Contract [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative	$ 0	$ 0	$ 0	$ 0
Location of Gain Reclassified from Accumulated OCI into Income (Expense)	Other Expense		Other Expense
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income	$ (19)	$ (20)	$ (59)	$ (60)

XML

Employee Retention Credit - Additional Information (Detail) - USD ($) $ in Thousands			1 Months Ended	6 Months Ended	9 Months Ended
	Mar. 22, 2022	Oct. 30, 2021	Jul. 31, 2021	Jun. 30, 2021	Oct. 29, 2022
Employee Retention Credit Disclosure [Line Items]
Erc Receivables	$ 3,100	$ 3,100
Cost of Sales [Member]
Employee Retention Credit Disclosure [Line Items]
Employee retention credit receivables		1,700
Selling and Marketing Expense [Member]
Employee Retention Credit Disclosure [Line Items]
Employee Retention Credit Receivable - selling and marketing					$ 800
Research and Development Expense [Member]
Employee Retention Credit Disclosure [Line Items]
Employee Retention Credit Receivable - research and development		$ 300
General and Administrative Expense [Member]
Employee Retention Credit Disclosure [Line Items]
Employee Retention Credit Receivable - general and administrative expenses					$ 300
Cares Act [Member]
Employee Retention Credit Disclosure [Line Items]
Percentage of refundable tax credit can be claimed of qualified wages				70.00%
Threshold qualified wages per employee per calendar quarter				$ 10,000
Maximum threshold employee retention credit per employee per calendar quarter				$ 7,000
Percentage of reduction of gross Receipts to qualify for employee retention credit			20.00%
Cares Act [Member] | Prepaid Expenses and Other Current Assets [Member]
Employee Retention Credit Disclosure [Line Items]
Employee retention credit received	$ 3,100

XML

Royalty Obligation - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Jan. 31, 2018	Oct. 29, 2022	Oct. 29, 2022	Jan. 31, 2022
Royalty Obligation, Current		$ 1,750	$ 1,750	$ 2,000
Royalty Obligation Non Current		3,298	3,298	$ 4,361
Guaranteed Minimum Royalty Payment		9,000
Excess Royaltie paid			900
Honeywell Asset Purchase and License Agreement [Member]
Payment Term Period	10 years
Minimum Royalty Payment Obligation	$ 15,000
Fair Value Assumption Percentage Of Present Value Factor	2.80%
Royalty Obligation, Current		1,800	1,800
Royalty Obligation Non Current		3,300	3,300
Accrued Royalties, Current, Excess Royalty Payment Due		300	300
Excess Royalty Payments Incurred		$ 300	$ 900

XML

Leases - Additional Information (Detail)	Oct. 29, 2022
Operating Lease, Weighted Average Remaining Lease Term	3 years 10 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent	3.86%

XML

Leases - Schedule Of Balance Sheet And Other Information Related To Operating Leases (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
Operating Leases [Abstract]
Right of Use Assets	$ 800	$ 1,094
Other Liabilities and Accrued Expenses	291	327
Lease Liabilities	$ 550	$ 808

XML

Leases - Lease Cost Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
General and Administrative Expense [Member]
Operating Lease Costs	$ 115	$ 125	$ 350	$ 386

XML

Leases - Maturities of lease liabilities (Detail) $ in Thousands	Oct. 29, 2022 USD ($)
Leases [Abstract]
Fiscal 2023, remaining	$ 74
Fiscal 2024	286
Fiscal 2025	186
Fiscal 2026	142
Fiscal 2027	137
Thereafter	85
Total Lease Payments	910
Less: Imputed Interest	(69)
Total Lease Liabilities	$ 841

XML

Leases - Supplemental cash flow information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Cash paid for amounts included in the measurement of lease liabilities [Abstract]
Operating cash flows for operating leases	$ 74	$ 85	$ 237	$ 285

XML

Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended							9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022	Oct. 30, 2021
Schedule of Capitalization, Equity [Line Items]
Beginning Balance		$ 81,096	$ 80,696	$ 81,012	$ 82,577	$ 75,533	$ 74,683	$ 81,012	$ 74,683
Other Comprehensive Loss	$ (481)	(481)	(419)	(917)	(394)	(333)	(65)	(1,817)	(792)
Ending Balance	81,328	81,328	81,096	80,696	82,182	82,577	75,533	81,328	82,182
Foreign Currency Translation Adjustments [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance				(1,701)				(1,701)
Other Comprehensive Loss before reclassification								(1,864)
Other Comprehensive Loss								(1,864)
Ending Balance	(3,565)	(3,565)						(3,565)
Net Unrealized Gain/(Loss) on Cash Flow Hedges [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance				(47)				(47)
Amounts reclassified from AOCL to Earnings								47
Other Comprehensive Loss								47
Ending Balance	0	0						0
Accumulated Other Comprehensive Income (Loss) [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance		(3,084)	(2,665)	(1,748)	(782)	(449)	(384)	(1,748)	(384)
Other Comprehensive Loss before reclassification								(1,864)
Amounts reclassified from AOCL to Earnings								47
Other Comprehensive Loss		(481)	(419)	(917)	(394)	(333)	(65)	(1,817)
Ending Balance	$ (3,565)	$ (3,565)	$ (3,084)	$ (2,665)	$ (1,176)	$ (782)	$ (449)	$ (3,565)	$ (1,176)

XML

Share-Based Compensation - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding	554,099		554,099		598,043
Number of options granted	0		0
Reservation of shares under Stock Purchase Plan			40,000
Restricted Stock or Unit Expense	$ 401,000	$ 369,000	$ 963,000	$ 1,147,000
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Stock Purchase Plan discount rate			15.00%
2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding	283,274		283,274
2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for grant under the Plan	950,000		950,000
Number of shares outstanding	135,500		135,500
2022 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchase under Employee Stock Purchase Plan			2,288
Shares available for grant under the Plan	37,712		37,712
Prior Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchase under Employee Stock Purchase Plan			1,550	5,684
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense to be recognized, Weighted average period			1 year
Unrecognized compensation expense related to RSUs and RSAs	$ 1,900,000		$ 1,900,000
Restricted Stock Units (RSUs) [Member] | 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unvested shares	128,262		128,262
RSA [Member] | 2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding	135,325		135,325
RSA [Member] | 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unvested shares	21,172		21,172
Performance Based RSUs [Member] | 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of unvested shares	128,793		128,793
Restricted Stock Award [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock or Unit Expense			$ 65,000

XML

Share-Based Compensation - Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Share-based Compensation [Abstract]
Stock Options	$ 0	$ 25	$ 7	$ 187
Restricted Stock Awards and Restricted Stock Units	401	369	963	1,147
Employee Stock Purchase Plan	4	4	7	11
Total	$ 405	$ 398	$ 977	$ 1,345

XML

Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail)	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Share-based Compensation [Abstract]
Beginning balance, Number of Options | shares	598,043
Exercised, Number of Options | shares	(36,444)
Forfeited, Number of Options | shares	(5,100)
Expired, Number of Options | shares	(2,400)
Ending balance, Number of Options | shares	554,099
Beginning balance, Weighted-Average Exercise Price Per Share | $ / shares	$ 14.67
Exercised, Weighted-Average Exercise Price Per Share | $ / shares	8.41
Forfeited, Weighted-Average Exercise Price Per Share | $ / shares	15.38
Expired, Weighted-Average Exercise Price Per Share | $ / shares	8.09
Ending balance, Weighted-Average Exercise Price Per Share | $ / shares	$ 15.1

XML

Share-Based Compensation - Summary of Options Outstanding (Detail) - $ / shares	9 Months Ended
	Oct. 29, 2022	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, total	554,099	598,043
Outstanding, Weighted Average Exercise Price	$ 15.1
Exercisable, Weighted Average Exercise Price	$ 15.1
Outstanding Remaining Contractual Life	3 years 10 months 24 days
Number of shares exercisable, total	554,099
Exercisable Remaining Contractual Life	3 years 10 months 24 days
$10.01 - $15.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 10.01
Outstanding Range of Exercise prices, Upper Limit	$ 15
Outstanding, Number of shares	339,549
Outstanding, Weighted Average Exercise Price	$ 13.62
Exercisable, Weighted Average Exercise Price	$ 13.62
Outstanding Remaining Contractual Life	3 years 1 month 6 days
Exercisable, Number of shares	339,549
Exercisable Remaining Contractual Life	3 years 1 month 6 days
$15.01 - $20.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 15.01
Outstanding Range of Exercise prices, Upper Limit	$ 20
Outstanding, Number of shares	214,550
Outstanding, Weighted Average Exercise Price	$ 17.45
Exercisable, Weighted Average Exercise Price	$ 17.45
Outstanding Remaining Contractual Life	5 years 1 month 6 days
Exercisable, Number of shares	214,550
Exercisable Remaining Contractual Life	5 years 1 month 6 days

XML

Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) - Restricted Stock Award And Restricted Stock Unit [Member]	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance, Outstanding Restricted Stock Units and Restricted Stock Awards | shares	220,980
Granted, Restricted Stock Units and Restricted Stock Awards | shares	141,371
Vested, Restricted Stock Units and Restricted Stock Awards | shares	(83,024)
Forfeited, Restricted Stock Units and Restricted Stock Awards | shares	(1,100)
Ending balance, Outstanding Restricted Stock Units and Restricted Stock Awards | shares	278,227
Beginning balance, Weighted Average Grant Date Fair Value | $ / shares	$ 12.79
Granted, Weighted Average Grant Date Fair Value | $ / shares	12.68
Vested, Weighted Average Grant Date Fair Value | $ / shares	13.41
Forfeited, Weighted Average Grant Date Fair Value | $ / shares	11.77
Ending balance, Weighted Average Grant Date Fair Value | $ / shares	$ 12.55

XML

Income Taxes - Projected Effective Tax Rate for Periods (Detail)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Income Tax Disclosure [Abstract]
Effective tax rates for income from continuing operations	26.00%	29.00%	22.80%	4.00%

XML

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 29, 2022	Oct. 31, 2021	Oct. 30, 2021
Income tax expense (benefit)	$ 102,000	$ (174,000)	$ 383,000	$ 383,000	$ 297,000	$ 297,000
Tax benefit related to the reversal of previously uncertain tax positions				13,000		30,000
Tax expense resulting from shortfall				300,000
Tax expenses benefits resulting from provisional adjustments				51,000		100,000
Effective income tax reconciliation tax expense due to revaluation of deferred tax assets	$ 30,000			$ 38,000
Forgiveness Of Loan Under Paycheck Protection Programme [Member]
Tax benefits resulting from forgiveness of debt						$ 1,100,000

XML

Segment Information - Net Sales and Segment Operating Profit (Loss) for Each Reporting Segment (Detail) - USD ($)	3 Months Ended							6 Months Ended	9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022	Oct. 29, 2022	Oct. 31, 2021	Oct. 30, 2021
Segment Reporting Information [Line Items]
Revenue	$ 39,405,000				$ 28,857,000				$ 102,674,000	$ 87,780,000	$ 87,780,000
Corporate Expenses	3,325,000				2,364,000				8,456,000		7,372,000
Operating Income	1,346,000				296,000				3,346,000	4,482,000	4,482,000
Other Income (Expense), Net	(955,000)				(895,000)				(1,665,000)	3,002,000	3,002,000
Income (Loss) Before Income Taxes	391,000				(599,000)				1,681,000	7,484,000	7,484,000
Income Tax Provision (Benefit)	102,000				(174,000)			$ 383,000	383,000	297,000	297,000
Net Income (Loss)	289,000	$ 289,000	$ 584,000	$ 425,000	(425,000)	$ 7,019,000	$ 593,000		1,298,000	7,187,000	$ 7,187,000
Product Identification [Member]
Segment Reporting Information [Line Items]
Revenue	29,879,000				21,928,000				74,985,000	68,519,000
T&M [Member]
Segment Reporting Information [Line Items]
Revenue	9,526,000				6,929,000				27,689,000	19,261,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Income	4,671,000				2,660,000				11,802,000	11,854,000
Operating Segments [Member] | Product Identification [Member]
Segment Reporting Information [Line Items]
Operating Income	2,960,000				1,818,000				6,019,000	8,952,000
Operating Segments [Member] | T&M [Member]
Segment Reporting Information [Line Items]
Operating Income	1,711,000				842,000				5,783,000	2,902,000
Corporate Expenses [Member]
Segment Reporting Information [Line Items]
Corporate Expenses	$ 3,325,000				$ 2,364,000				$ 8,456,000	$ 7,372,000

XML

Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 31, 2022
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	$ 14,667	$ 9,255
Fair Value [Member] | Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	14,667	9,255
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term debt and related current maturities	$ 14,625	$ 9,250